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STEVOR proteins have been identified as the members of the third largest 
variant antigen family exported by P. falciparum parasite. Being expressed in 
different stages of parasite life cycle, these proteins have been believed to be 
involved in important functional attributes associated with disease pathology. 
Presently, the dynamics of STEVOR export and its arrangement on the iRBC 
surface at late asexual stages are not understood well. Critically, the relevance 
of STEVOR mediated rosetting under physiological conditions is also not yet 
clear. Hence, this thesis is focused on studying physiologically relevant 
expression pattern and functional study of STEVOR antigens on late stage 
iRBCs in asexual life cycle. 
In this study, using a combination of highly sensitive molecular force 
spectroscopy and immunogold labeling electron microscopy, we investigate 
the dynamics of STEVOR surface expression proteins in asexual iRBCs. We 
also provide new insights into the spatial and temporal surface expression 
profile of STEVOR, showing the clustering of protein molecules on the iRBC 
surface and their preferential proximity to knobs. Using dual pipette force 
assays and microfluidics based rosetting assays, we further demonstrate that 
these proteins can directly mediate the formation of stable and robust rosettes 
under static and flow conditions. This strongly suggests that STEVOR 
mediated rosettes can contribute to parasite mediated pathology under 




Overall, our work demonstrates the physiological importance of STEVOR at 
asexual stages of parasite development. Taken along with the known functions 
of other variant antigens, it outlines the context in which these various proteins 
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1.1  Malaria 
Malaria is a parasitic disease with a huge global health burden. Globally, an 
estimated 3.3 billion people in 97 countries and territories are at risk of being 
infected with malaria and developing this disease (Figure 1.1), and 1.2 billion 
are at high risk (>1 in 1,000 chance of getting malaria within a year). 
According to the latest estimates, 198 million cases of malaria occurred 
globally in 2013 and the disease has led to about 584,000 deaths, representing 
a decrease in malaria case incidence and mortality rates of 30% and 47% since 
2000, respectively [1]. The burden is heaviest in the African region, where an 
estimated 90% of all malaria deaths occur, and in children aged under 5 years, 
who account for 78% of all deaths. 
It primarily affects low and lower-middle income countries. Within the 
endemic countries, the poorest and most marginalized communities are the 
most severely affected, having the highest risks associated with malaria, and 
the least access to effective services for prevention, diagnosis and treatment. 
Thus, malaria control and ultimately its elimination is inextricably linked with 






Figure 1.1: Countries with ongoing transmission of malaria, 2013 [1]. 
 
The term malaria designates the disease produced by infection with any of the  
five human parasites of the genus Plasmodium (P.) -  
P. falciparum, P. vivax, P. malariae, P. Ovale and P. knowlesi . These parasites 
are transmitted from one human to another by the bite of a female mosquito of 
the genus Anopheles, and are very selective of their vertebrate host, so that 
human malarias have no animal reservoir. There are about 400 different 
species of Anopheles mosquitoes, but only 30 of these are vectors of major 
importance [2]. In recent years, human cases of malaria have also been 
recorded due to P. knowlesi – a species that causes malaria among monkeys, 
and occurs in certain forested areas of South-East Asia [3]. Of all human 
species, P. falciparum is most prevalent in the African continent, and is 
responsible for most deaths from malaria. P. vivax has a wider geographic 
distribution than P. falciparum [1] because it can develop in the Anopheles 
mosquito vector at lower temperatures, and can survive at higher altitudes and 





1.2  History of malaria 
Deadly fevers - probably malaria - have been recorded since the beginning of 
the written word (6,000 - 5,500BC) and references can be found in the vedic 
writings of 1,600BC in India and by Hippocrates some 2,500 years ago [4]. A 
syndrome with cyclic chills and fever thought to be malaria was described in 
the ancient Chinese literature [5] and in the Ebers papyrus (1,570 BC) [6]. 
Subsequently malaria was mentioned in Homer's Iliad, in Aristophanes' Wasps 
[6] and in Shakespeare's The Tempest [7]. 
Hippocrates is usually credited with the first clear description amongst 
occidental writers. In Europe, seasonal periodic fevers were particularly in 
marshy areas and were frequently referred to as "paludial" (L. palus marshy 
ground; Fr. paludisme, sp. paludismo). In the beginning of the 19
th
 century, 
Italian writers put forward the thought that malaria was caused by foul vapors 
from the marshes, hence the name malaria meaning "bad air" (It. mal aria).  
1.3  The malaria parasite  
1.3.1  The parasite 
The malaria parasites belong to genera of plasmodia and are protozoan 
parasites of mosquitoes, liver- and red blood cells. They are related to other 
parasites such as toxoplasma, cryptosporidia and babesia that also belong to 
the subphylum apicomplexa. More than hundred plasmodia have been 
described occurring in mammals, birds and lizards [8]. There are five species 
of plasmodia that infect humans - P. vivax, P. ovale, P. malariae, P. knowlesi 
and  P. falciparum. These share the same life cycle with only minor 
differences. P. falciparum is the most common and most deadly of the malaria 




of cases with fatal outcome. 
1.3.2  Life cycle 
1.3.2.1  Asexual life cycle 
The general life cycle of malaria parasites is complex and the parasite goes 
through many changing stages both in the mosquito and in the human host. 
The infection starts when an infected anopheles mosquito takes a blood meal 
and injects up to a few thousand sporozoites into the blood stream (Figure - 
1.2). They circulate for a short time in the blood stream and will then rapidly 
home to the liver where they invade the liver cells. During the next 5-15 days, 
they will develop into exoerythrocytic schizonts. An exoerythrocytic schizont 
contains 10,000-30,000 merozoites which are released into the blood stream, 
where they invade the red blood cells (RBCs). This starts the "blood stage 
cycle" of the parasite, and it is here that the symptoms of the disease are 
manifested [10].  
The cycle begins with the entry of the extracellular merozoite into the RBC in 
a process known as invasion. This process is mediated by a number of 





different protein interactions between the merozoite and the target RBC. It 
ends in the complete entry of the merozoite into the RBC and the resealing of 
the RBC membrane. At this point, the free form of the parasite is no longer 
exposed to the immune system of the host. When the merozoite has entered 
the RBC, it grows into asexual trophozoite. The trophozoite grows and divides 
to eventually form erythrocytic schizont. After maturation of the schizonts, the 
erythrocytes burst, each liberating 8-24 merozoites that will again invade new 
RBCs and the cycle is repeated [10]. The periodicity of the erythrocytic cycle 
varies between the subspecies of human Plasmodia; in vivax, ovale and 
falciparum it is 48 hours and in malariae 72 hours. It is during the rupture of 
the RBCs that the classic symptoms of fever, chills and nausea appear.  
1.3.2.2  Sexual life cycle 
Some of the merozoites that invade RBCs will develop along a different path 
and form gametocytes, i.e., male and female sexual forms that can be taken up 
by a feeding mosquito. In the gut of the mosquito, the gametocytes mature and 
fertilization occurs and produces a motile egg that encysts in the gut wall and 
produces sporozoites that will complete the life cycle by invading the 
mosquito salivary glands. 
P. vivax and P.ovale have a dormant stage and can remain in the liver cells for 
weeks or years before developing into exoerythocytic schizonts. This results in 
relapses of infection. Both P. falciparum and P. malariae are persistent 
infections but they do not have dormant stages, and once the infection is 






1.4  Malaria control 
Choloroquine was the first medicine discovered for successful treatment of 
malaria. The research for antimalarials was intensified after this discovery and 
a number of new compounds have been synthesized. 
Effective community measures, in combination with anti malarial drugs, have 
been able to control the disease in many parts of the world.  
Since 2000, the financing and coverage of malaria control programmes has 
increased remarkably. This has resulted in a wide-scale reduction in malaria 
incidence and mortality rates. Of 106 countries with ongoing transmission of 
malaria in 2000, 64 are meeting the Millennium Development Goal (MDG) 
target of reversing the incidence of malaria. Of these 64 countries, 55 are on 
track to meet the World Health Assembly and Roll Back Malaria (RBM) 
targets of reducing malaria case incidence rates by 75% by 2015. Global 
estimated malaria case incidence rates fell by 30% between 2000 and 2013, 
while estimated mortality rates fell by 47% [1]. 
1.5  Malaria pathogenesis 
Among the four species of human malarias, P. falciparum stands out as the 
most malignant form and the only one where severe complications such as 
cerebral malaria, severe anemia, renal failure and pulmonary affection are 
frequently observed. 
Two features, important for disease severity and pathogenesis, separate P. 
falciparum from the other human malarias; the ability to invade RBCs of all 
ages causing very high parasitemias, and the capacity to adhere to vascular 
endothelium and types of cells through the process of sequestration (Figure - 




parasite derived proteins expressed on the surface of the RBC. This enables 
the parasite to avoid clearance by the immune system in the spleen. Moreover, 
P. falciparum is the only human malaria where several merozoites can invade 
a single erythrocyte, which rapidly produces high parasitemias. Genetic 
differences between individuals regarding the immune response mounted by 









Figure 1.3: A schematic showing the pathological scenario in a blood vessel. P. 
falciparum infected Red Blood Cells (iRBCs) can bind to varieties of 
receptors on different types of cells [22]. 
 
Many hypotheses have been formulated to explain the pathology behind 
severe falciparum malaria, two of which are "the mechanical obstruction" 
theory and "the cytokine/inflammatory response" theory [11] both of which 
have been proposed based on the clinical observations from patient isolates. 
Further research on these clinical findings reveals various molecular 
mechanisms employed by the parasite in order to protect itself from (i) spleen 
clearance, and (ii) immune attack. As such, the two theories are quite 
interlinked with each other and a complete understanding of the disease 




part of the scope of this study, we will discuss, in brief, about the two main 
survival strategies adopted by the parasite which form the basis of these 
hypotheses. These strategies are: (i) microvascular sequestration, and (ii) 
antigenic variation. 
1.5.1  Microvascular sequestration 
During its life cycle in human host, the parasite brings about drastic changes in 
the natural attributes of the host RBC. This makes the cell more susceptible to 
spleen clearance. In order to be able to circulate through the spleen system, the 
parasite remodels the RBCs and makes it adhere to different types of cells 
including endothelial cells in blood vessels (cytoadherence) and other 
uninfected RBCs (uRBCs) (rosetting). 
1.5.1.1  Cytoadherence 
The adhesion of iRBCs to post capillary venular endothelium is believed to be 
a major virulence factor in creating mechanical obstruction of blood vessels 
[12, 13]. It can lead to further complications such as cerebral malaria, 
placental malaria and severe malaria [13-17]. Clinical studies have 
demonstrated positive correlations between the extent of sequestration in the 
cerebral blood vessels and the severity of the disease [18-20]. Furthermore, 
autopsy reports showed that individuals with cerebral malaria also exhibit a 
high degree of IE sequestration in small blood vessels of other internal organs 









The microvasculature obstruction induced by cytoadhesion between iRBCs 
and host receptors in placenta of pregnant women, is extremely dangerous to 
both mother and child, and it can lead to hypoxia, inflammatory reactions and 
chronic intervillositis (figure 1.4(B)) [16]. This can cause premature delivery, 
low birth weight, anaemia in mother and can eventually lead to death of 
mother, abortion of fetus and a stillbirth [11, 14, 23]. Infected erythrocytes can 
be found bound to microvasular endothelium in several organs throughout the 
body [24]. It is believed that when iRBCs bind to the endothelium in large 
numbers, specific organ dysfunction and associated clinical manifestations 
occur by a variety of possible mechanisms. These may include poor local 
perfusion [25], local release of cytokines and nitric oxide [26, 27] and local 
metabolic disorders [28]. 
Not only asexual forms have been described to sequester; gametocytes have 
also been reported to adhere to different receptors on endothelium and in the 
bone marrow [29-31]. This may be important for maturation of gametocytes 
before they are transmitted back to the mosquito vector. 
Figure 1.4: (A) A section of brain from a patient with cerebral malaria [13]. 




1.5.1.2  Host receptors for cytoadherence 
A wide range of endothelial receptor molecules have been proposed to be 
involved in cytoadherence, including CD36 [32, 33], thrombospondin (TSP) 
[34], Inter-Cellular Adhesion Molecule - I (ICAM-1) [35], Chondroitin Sulfate 
A (CSA) [36], P-Selectin [37], E-Selectin [38], Vascular Cell Adhesion 
Molecule 1 (VCAM-1) [38], Platelet-Endothelial Cell Adhesion Molecule 1 
(PECAM-1) [39], etc. The extent of up regulation of these different receptors 
is observed to vary in different organs and also from patient to patient. Most of 
the parasite clones from patient isolates seem to bind the receptor CD36, 
whereas the binding efficiency to other receptors like ICAM-1, VCAM-1, etc., 
appears to be more variable. All these factors may affect the ultimate clinical 
symptoms and the pathogenesis of the disease [40].  
1.5.1.3  Rosetting 
The adhesive properties of iRBCs do not only cause binding to endothelium, 
but also make them adhere to other uRBCs. This phenomenon, known as 
rosetting, is defined as the spontaneous binding of two or more uRBCs to the 










Of the human malarias, rosetting is most commonly seen with P. falciparum, 
but has also been reported to occur with P. vivax, P. malariae and P. ovale 
[41-43, 172, 173] although the mechanisms and role in the pathogenesis are 
still being understood in the case of latter three. One of the recent works have 
shown the involvement of Glycophorin C on the surface of uRBCs as a 
receptor in rosetting phenotype of P. vivax parasite [41].  
Typically, for P. falciparum malaria rosetting phenotypes have been 
associated with the severity of the disease [44-46, 165] and it has been 
postulated that antibodies that disrupt rosettes may confer protection against 
cerebral malaria [44, 47]. Other studies, however, have demonstrated a lack of 
correlation between rosetting and severe disease [48, 198]. The exact set of 
explanations behind the apparent differences between these clinical findings is 
not available yet. 
The exact role of rosetting in the cascade of events that bring about severe 
malaria is also not fully understood. However, several hypotheses have been 
put forward in this regard. Formation of rosettes around late stage infected 
RBCs may help shield the parasites from various immune cells, which is 
believed to be one of the primary mechanisms of clearing the parasite 
infection [49]. Rosetting has also been suggested to increase the level of 
mechanical obstruction in blood vessels by creating aggregates of cells at 
various locations [200]. Finally, formation of rosettes may also facilitate the 
migration of emerging merozoites into uRBCs within the rosette especially 
under dynamic conditions [163]. 




iRBCs rupture, combined with microvasculature obstruction due to 
cytoadherence and rosetting phenotypes, can lead to serious complications 
such as impaired consciousness, coma, difficulty in breathing, severe anemia 
and multi-organ failure [11, 15, 50]. 
1.5.1.4  Host receptors for rosetting 
Multiple host receptor molecules have been identified to be involved in 
rosetting interactions. Studies have implicated Heparan Sulfate [163, 164], 
CR1/CD35 [171], CD36 [187], Immunoglobulins [104, 164] and blood group 
antigens [102, 105]. The binding affinity and binding strength of the parasite 
in rosetting with different receptors has been found to vary depending upon 
many factors, including the kind of parasite strain and host immune system. 
1.5.2  Antigenic variation 
The success of pathogenic microbes depends upon their ability to colonise 
host tissues, counter host defence mechanisms, and to ensure long-term 
survival by maintaining infectivity through transmission. The term antigenic 
variation refers to the mechanism in which an infectious organism alters its 
surface proteins in order to evade a host immune response. The strategy is 
particularly important for organisms that a) target long-lived hosts, b) 
repeatedly infect a single host, and c) are easily transmitted. Antigenic 
variation can occur through three broadly defined genetic processes: gene 
mutation, recombination, and switching. In all cases, antigenic variation 
results in pathogens that are immunologically distinct from the parental strains. 
Antigenic variation in Plasmodium is due to gene switching. Each parasite 
devotes approximately 2% to 6% of its genomic DNA to a reporoire of 




Transcription of the var genes can occur from expression sites internal on the 
chromosomes or near a chromosome telomere. Changes in var expression 
appear to occur in situ by recombination-independent mechanisms [59, 66, 67, 
103]. The antigenic variation in P. falciparum is, to a large extent, believed to 
be mediated by the var genes family, other variant antigen families like stevor, 
rifin have also been reported to be involved in this survival strategy of the 
parasite [100, 101]. More details will be discussed in subsequent subsections. 
1.6  Molecular mechanisms in P. falciparum pathology 
The ability of parasites to sequester in microvasculature and to exhibit 
antigenic variation have been attributed to various proteins exported by the 
parasite in different parts of the iRBC including the cell membrane surface. 
Export of various binding ligands to the iRBC surface and other sub-cellular 
locations is achieved by a highly organized and sophisticated remodeling 
network established by the parasite within the host RBC. 
The sequestration involves molecular interactions between surface exposed 
ligands on iRBCs and host receptors. Many of these receptors which get 
unregulated during the disease and are targeted as binding molecules by 
iRBCs, have been described in earlier subsections of this chapter. In this part, 
an analysis from parasite's perspective will be presented.  
For antigenic variation, parasite is able to export different Variant Surface 
Antigen (VSA) families on the surface of the iRBC. Few major families will 





1.6.1  RBC remodeling by the parasite 
The mature RBC, itself optimized for the function of oxygen delivery, lacks 
the internal cellular architecture & functions of other cells, such as a nucleus 
and the machinery to express and transport proteins [51]. Upon infection, 
Plasmodium falciparum parasite completely remodels the host RBC, by 
generating its own intracellular organelles and protein transport machinery. 
This constitutes a crucial set of mechanisms as a part of survival strategy 
adopted by the parasite. The complicated process of remodelling starts 
immediately after the merozoites invade the RBC and occurs through the 
expression of a large set of specialized proteins that are trafficked via a 
sophisticated export pathway into the host cell [52, 53]. Upon invasion, the 
merozoite enters with part of the RBC membrane which later goes on to form 
the parasitophorous vacuolar membrane (PVM) [54, 55]. The pre-existing 
merozoite membrane becomes the parasite plasma membrane (PPM). Thus, 
the parasite now has three membranes that separate it from the extracellular 
milieu of the host, i.e., the PPM, the PVM and the RBC membrane, as shown 










Remodelling is dependent on construction of an extra-parasitic trafficking 
network in the host cell that distributes and sorts exported proteins to their sub 
cellular locations [9].  
1.6.2  Parasite derived surface associated antigens on iRBC  
Using this sophisticated transport system, the parasite exports a full arsenal of 
different kinds of proteins in different parts of the host RBC, including the cell 
membrane (figure 1.7). A large number of proteins have been identified as 
components of various stages in the parasite life cycle, but here only few 
majors players, associated with the iRBC surface membrane, will be discussed 
here in detail. 
Many of these antigens are structurally polymorphic and constitute the 
molecular basis for various functional phenotypes observed with different P. 
falciparum strains and isolates.  
Figure 1.7: Membrane sections of (A) uninfected RBC. Regular arragement of 
various membrane and cytoskeletal proteins can be observed. (B) infected 
RBC. Numerous parasite derived proteins are exported into the RBC 
membrane. These proteins interact with host proteins and alter the regular 
architecture of the cell membrane and cytoskeletal network. KAHRP proteins 
can be observed to accumulate under the membrane, producing knobby 





1.6.2.1  KAHRP 
Knob Associated Histidine Rich Protein (KAHRP) is one of the best-studied 
proteins in P. falciparum infection. This protein is exported soon after the 
merozoite invades the RBC. After export, KAHRP concentrates around the 
cytoplasmic face of Maurer’s clefts [77], possibly associating with the 
cytoplasmic acidic terminal sequence (ATS) domain of PfEMP1 [62, 73]. 
Recent in vitro binding studies suggest that KAHRP may not directly interact 
with the ATS but that another exported protein, having a PHISTc domain 
(PF3D7_0936800), may bind [78]. This is consistent with other studies that 
indicate the existence of electrostatic interactions between KAHRP and 
PfEMP1 [72, 73]. After interacting with Maurer’s clefts, KAHRP then traffics 
to and binds host spectrin in the cytoskeleton [62, 79] to generate one of the 
most prominent features of the P. falciparum–infected erythrocyte, knobs, 
which are a principal component of the cytoadherence complex.  
Knobs are electron dense protrusions found in the iRBC membrane, measuring 
30-40 nm in height and average 100nm in width [54]. Knobs have been 
suggested to be crucially important for cytoadherence and virtually all field 
isolates exhibit these protrusions, but some very adhesive laboratory strains 
lack knobs as do some field isolates [80].  
1.6.2.2  PfEMP1 
Almost all cytoadherence of P. falciparum–infected erythrocytes is conferred 
by expression of a high molecular-weight protein, P. falciparum erythrocyte 
membrane protein 1 (PfEMP1). PfEMP1 has been identified as a strain 




of the iRBC [60-63].  
Export of the protein PfEMP1 is a complex and multistep process as it is large 
with a variable number of folded domains. PfEMP1 expression starts 4 hour 
post invasion and does not appear on the surface of the P. falciparum–infected 
erythrocyte until 16 h; however, it is trafficked to and stored in Maurer’s clefts 
[62, 81, 82]. On the surface, these proteins form clusters of different sizes and 
a fraction of surface exported PfEMP1s get localized on the surface of knobs 
by interacting with the anchoring base of knobs, KAHRP [70, 72]. The nature 
of this interaction has been believed to be electrostatic in nature as suggested 
by some studies [63, 73]. The clustering of PfEMP1 on knobs has been found 
to be critical for cytoadherence of iRBCs in in-vitro flow assays [70, 71]. In a 
very recent study, the density of knobs on the surface of the iRBC has been 
shown to be directly linked to the variant of PfEMP1 expressed in that 
particular clone [74]. 
PfEMP1 has been recognised as one of the biggest ligands exposed on the 
surface of the iRBC with multiple domains to bind a large variety of receptors 
in the host body including: blood group A, CSA, CD36, HS, ICAM-1, IgM, 
PECAM-1/CD31 and TSP [168-171]. The general structure and the two most 





Figure 1.8: The prototypical PfEMP1 extracellular region (a) consists of an 
NTS and DBL1α–CIDR1 ‘semi conserved head structure’ followed by a 
DBL2δ–CIDR2 tandem. Larger PfEMP1 proteins (b) also include the DBLβ, γ 
and ε types arrayed differently. Mapped binding traits are indicated with the 
domain and sequence class that is bound [76]. 
 
All PfEMP1 peptides cloned are composed of an N terminal duffy-binding-
like-domain (DBL-1), a cystein-rich-inter-domain-region (CIDR), a 
hydrophobic transmembrane region and a conserved cytoplasmic acidic 
terminal sequence (ATS). One or more additional DBLs with some general 
structural similarity to DBL-1 are found in some PfEMP1s.  
Various studies have shown PfEMP1 to be capable of mediating 
cytoadherence and rosetting phenotypes in static and dynamic conditions [177, 
178, 64, 65]. 
This protein group is also the biggest VSA family exported by the parasite on 
the surface of the iRBC [134] and thus plays a very crucial role in the 
antigenic variation ability of the parasite. Its role in antigenic variation will be 
discussed in later subsection. 
1.6.2.3  Other surface associated proteins 
Some of the other known proteins exported to the iRBC membrane are 
Pf155/RESA (Ring Infected Erythrocyte Surface Antigen) [83], PfEMP3 
(Plasmodium flaciparum Erythrocyte Membrane Protein 3) [86], 
PfEMP2/MESA (Plasmodium flaciparum Erythrocyte Membrane Protein 3/ 
Mature Erythrocyte Surface Antigen) [85], Pf332 [84], Clag 9 [87]. Many of 
these proteins have been characterized to be involved in cytoskeleton related 




The renovation of host erythrocytes by exported parasite proteins ensures the 
parasite’s survival but also contributes to virulence and pathogenesis of 
malaria. 
1.6.3  Variant Surface Antigen (VSA) families in P. falciparum 
1.6.3.1  The var gene family 
Encoded by approximately 60 var (variable) genes per haploid genome [134], 
the PfEMP1 protein family displays enormous sequence diversity and host-
cell-binding selectivity, and these features contribute to the spectrum of 
disease severity and pathology [66]. It has been shown that about 50-150 
variants of var genes can be expressed in one population but only one is 
activated at a time on a single cell which can be switched at a rate of around 2% 
per generation [67, 68]. The ability to switch var gene expression provides a 
mechanism of antigenic variation important for evasion of host immune 
responses [69]. The PfEMP1 family proteins are targets of acquired immunity 
during infection and may be candidates for development of interventions 
against malaria [75]. However, the significant diversity of this protein family 
in the P. falciparum population is a possible impediment to this goal. 
1.6.3.2  The rif gene family 
Rif (Repetitive Interspersed Family), one of the largest multi gene families in P. 
falciparum, encodes clonally variant rifin proteins [96]. This family is present 
in about 149 copies in the 3D7 genome. They are present at the sub-telomeric 
ends of all 14 chromosomes [100, 101]. The predicted structure of rifins 
comprises of a cysteine rich N-terminal and a C-terminal region that contains a 




subtypes of rifins have been characterized in studies - rif A and rif B. While 
type B rifin has been shown to be expressed on merozoite and gametes [96], 
type A is believed to be exported to the iRBC membrane [98]. There is also 
evidence to show that the rifins are transcribed at the gametocyte stage; 
however, whether they are exposed on the iRBC surface is as yet unclear [100]. 
A recent study shows that rifins can also mediate rosetting interactions of 
iRBCs with uRBCs with preferential affinity for certain blood group types 
[102].  
1.6.3.3  The stevor gene family 
Stevors (Sub Telomeric Open Reading Frame) constitute the third largest 
variant antigen family of Plasmodium falciparum [96]. This gene family is 
comprised of 33 members in the reference clone 3D7 and they are present at 
the sub-telomeric ends of all 14 chromosomes. Multiple variants of the protein 
have been detected and around 2-3 members of the family have been shown to 
be transcribed at a single iRBC level [133, 134]. Field studies have as well 
demonstrated that stevor expression in patient isolates is much higher as 
compared to lab cultured strains [192], linking this protein family to the extent 
of antigenic variation exhibited by the parasite under immune pressure. 
Another study showed that stevor family could express different variants of 
stevor within subpopulations of the strain 3D7 [109]. These observations 
support the functional involvement of stevor in evading the immune system. 
However, only a limited number of direct studies have been carried in this 
regard [88]. More extensive tests are required to establish the direct role of 
stevor multigene family in antigenic variation of the parasite.  




Previous bioinformatics predictions indicated the presence of a signal peptide, 
PEXEL motif, hypervariable (HV) region and two TM domains that flank a 
semi-conserved (SC) region as shown in the figure 1.9 below.  
The percentage values express the degree of conservation between different 
members of the family. Owing to its variant sequence, HV region was believed 
to be exposed on the extracellular surface of the iRBC, if the protein was 
exported to the surface. Combining this with 2TM structure predictions, SC 
region should be located in the intracellular region. Experimental studies, 
however, provide evidences challenging the 2TM model and suggest that 
stevor domain architecture comprises a single TM domain, with both, the HV 
and SC regions exposed on the extracellular side of the iRBC surface, and a 
short cytoplasmic tail anchoring the protein.  
Stevor has been shown to be expressed during the asexual and sexual stages of 
the parasite life cycle [165] and is believed to perform distinct functions at 
these stages. At late trophozoite stages, stevor has been co-localized with 
PfSBP1, a well known marker for Maurer's Clefts (MCs) [89], and PfEMP3 
[90, 91]. Other studies have localised these proteins with iRBC membrane at 
late asexual stages [109, 192]. A more recent study has demonstrated that the 
PfPTP1 protein, which is known to be important for trafficking of PfEMP1 to 
the iRBC membrane via the MCs, is also essential for stevor transport [92].  
Functionally, stevor has been implicated in increasing the rigidity of the iRBC 
membrane at late asexual stages [93]. Other experimental studies suggest that 





stevor contributes to increase the deformability of gametocytes in stage III & 
IV and the change in stevor expression on gametocyte surface has been 
correlated with abrupt switch of deformability from stage IV to stage V 
gametocytes [94]. 
Interestingly, stevor is also present at the apical tip of the merozoite, and its 
role in parasite invasion was recently confirmed [179]. Studies have also 
shown that different variants of stevor are expressed at merozoite surface and 
schizont stage parasite, [106, 107] thus further supporting the hypothesis that 
stevor family is involved in antigenic variation.  
During the asexual replication cycle, the peak of stevor transcription occurs at 
around 28 hours post invasion (mid-trophozoite stage), as seen in cultured 
strains [90]. Recently, it has been shown in patient isolates that another peak 
of transcription occurs at the early ring stage [95]. Interestingly, the same 
variants of the gene family were expressed during both peaks. This indicates 
that the protein may have an additional role during the early stages of parasite 
development, and also poses the question as to why and how the parasite 
lowers transcript levels between the two peaks.  
1.7  Motivation of the thesis 
STEVOR, the third largest variant antigen family in P. falciparum malaria, has 
been shown to be associated with different stages of parasite life cycle. Studies 
have also attempted to study the possible functions these proteins may be 
involved in at different stages. As described earlier, some of the recent works 
have provided evidences that variant STEVORs are exposed on the surface of 
the iRBC at late asexual stages. However, due to increased permeability of 




labeled with STEVOR antibodies, may not be a satisfactory proof to establish 
the presence of STEVOR on extracellular surface. The spatial resolution of the 
confocal microscope further limits this localization strategy. This leaves us 
with following questions to address: 
1.  Can the presence of STEVOR on late stage iRBC surface be 
established using a more accurate, effective and reliable protocol? 
2.  Does the surface expression of STEVOR remain constant or it varies 
with stage of parasite maturity? 
3.  How does the exact spatial and temporal surface expression pattern of 
STEVOR look like during the asexual life cycle? 
Also, some recent works have implicated STEVOR in rosetting interactions of 
late asexual iRBCs with uRBCs [179]. However, following questions remain 
to be addressed: 
1.  Are the rosettes mediated by STEVOR stable enough as compared to 
the rosettes formed by PfEMP1, the well studied mediator of 
cytoadherence and rosetting in P. falciparum malaria? 
 
2.  Are STEVORs capable of mediating the formation of stable rosettes in 
physiologically relevant dynamic conditions?  
 
1.8  Hypothesis, objectives & scope of the work 
Based on the above observations from literatures, we have formulated 
following hypotheses in this thesis: 
 




iRBC at late asexual stages of parasite development". 
 
2.  "STEVOR proteins are capable of mediating the formation of stable 
and robust rosette clusters under static as well as physiologically 
relevant flow conditions". 
 
To address our aforementioned hypotheses, the work has been divided in three 
main parts. Following are the detailed objectives in each part: 
Part 1: Surface exposure of STEVOR 
Objectives: 
1.  To develop and validate an effective molecular probing protocol for   
            investigating the presence of STEVOR on the iRBC surface. 
2.  To quantify the change in STEVOR surface expression in a stage 
            dependent manner. 
3.  To establish a relevant domain architecture model for STEVOR, based 
            on molecular probing tests. 
Part 2: Spatial distribution of STEVOR on iRBC surface 
Objectives: 
1.  To analyze the detailed spatial distribution patterns of STEVOR on 
iRBC surface at late asexual stages, and 
2.  To investigate the localization of STEVOR molecules in reference to 
             positions of knobs on the iRBC surface. 





1.  To study and quantify the contribution of STEVOR in rosetting assays 
             under static conditions. 
2.  To test the ability of STEVOR to mediate the stable rosetting     
interactions in physiological dynamic conditions and to check if these           
rosettes could survive in higher shear stress environment. 
A set of selected and engineered strains and a combination of hierarchical 
biophysical techniques will be employed to check our hypotheses and to 
address the concerned questions. Firstly, at nanoscale, a specific and sensitive 
molecular probing protocol will be established to detect the presence of 
STEVOR proteins on the iRBC surface. This technique, in combination with 
EM microscopy, will also be used to characterize the distribution pattern of 
STEVORs on the iRBC surface. Next, biophysical measurements at single cell 
level (microscale) will be performed to determine the role of STEVOR 
proteins in formation of static rosettes, if any. This will involve quantification 
of binding forces in rosettes from different clones. The data obtained will be 
processed to estimate the contribution of STEVOR in mediating the rosetting 
interactions. Lastly, microfluidics assays, at multi-cell level (population level) 
will be established to investigate if STEVOR proteins can enable the parasite 
to form rosettes in physiologically relevant flow conditions.  
This study will help us gain interesting and useful insights into the P. 
falciparum disease. The findings from our work may enable us explain some 
of the important and fundamental questions in P. falciparum malaria pathology 
- What is the exact spatio-temporal surface expression profile of STEVOR, the 




importance of STEVOR in parasite's efforts to maintain a long lasting 
infection cycle? and, why STEVOR is exported to the iRBC surface after 
PfEMP1 with a time delay?. Answers to all these questions will not only carry  
critical significance in better understanding the clinical pathology of the 
disease but may also help to develop better therapuetic drugs  to combat the 
disease. The detailed expression dynamics of STEVOR group will help us 
understand, in greater detail, about the complex antigenic diversity that is 
exhibited the parasite in order to deceive the host immune system and 
maintain the infection cycle. The revealed expression and distribution patterns 
of STEVOR may also explain the mechanisms adopted by these molecules in 
remodeling the host RBC skeleton and ultimately affecting the mechanical and 
morphological attributes of the cell. Quantitative biophysical investigations 
into the functional relevance of STEVOR in mediating stable and robust 
rosetting interactions will provide deeper insights into the multiple ligands 
mediated parasite pathology. These results may provide enhanced 
understanding into the complex time dependent interplay between the protein 
trafficking machinery of parasite and types of functional phenotypes displayed 
by the parasite. This might further help in developing more effective 
therapuetic molecules which could target to prevent or even reverse the 
clinical complications associated with cytoadherence and rosetting based 
sequestration in fine blood capillaries. Overall, this work can potentially open 
up new avenues of investigations and drive future efforts to uncover the yet 
unexplored aspects of the disease and develop next generation therapuetic 

















Localization and distribution of STEVOR 
during asexual stages of infection 
 
2.1 Preview 
This chapter describes the details of the investigative experiments to probe the 
exposure and stage-dependent expression pattern of STEVOR on the iRBC 
surface at late asexual stages. Part of this work was done in collaboration with 
Kripa Madnani, NTU. 
First, we will describe the preparation and isolation strategies for different 
parasite clones used in this entire study. Next, we will present the procedure of 
establishing an effective AFM based force mapping protocol to investigate 
STEVOR proteins on the surface of iRBCs. Then, we will describe the set of 
control experiments performed and details of data processing framework that 
were developed to optimize and validate the above protocol. After developing 
the optimized experimental protocols, we will present our results pertaining to 
the probing of STEVOR proteins and answer the question if STEVORs do get 
exposed on the extracellular surface of iRBCs. Next, we will proceed to 
analyze the stage dependency in terms of surface STEVOR distribution levels 
on iRBCs. Finally, based on our results, we will also discuss the architecture 





2.2  Introduction 
2.2.1  Background 
As described in the previous chapter, earlier studies have established the 
multistage transcription of STEVOR antigens in P. falciparum life cycle and 
have provided qualitative evidences about localization of these proteins in 
different parts of iRBCs [106, 107, 108]. However, an exact spatio-temporal 
expression profile of STEVOR, especially at late asexual stages, has been 
lacking so far. Studies have been performed using live IFA imaging of iRBCs 
to claim that STEVOR co-localizes with iRBC membrane at late asexual 
stages [109]. However, as the permeability of iRBC gets progressively 
modified with progress of infection stages, staining antibody molecules may 
pass through the RBC membrane and bind even to intracellular STEVOR 
molecules. Thus, the limited spatial resolution of the confocal microscopy 
technique may make it difficult to conclude if the molecules are exposed on 
extracellular surface or localized just beneath the surface.  
Here, using a combination of a set of selected and engineered parasite strains 
and AFM technique, we established an effective probing protocol and 
investigated the presence of STEVOR antigens on the surface of late stage 
iRBCs. 
2.2.2  Set of parasite clones 
The first important component of the study was selection of right parasite 
strains. The selected strains should have indicated the contrasting levels of 




different expression levels of STEVOR proteins. This work was carried out in 
our collaborator Prof. Peter Preiser's lab. 5A strain, which shows over 
expression levels of STEVOR, was obtained by limited dilution of parent 3D7 
strain as described in [109]. Another strain A4, obtained as a kind gift from 
Sue Kyes, Weatherall Institute of Molecular Medicine, Headington, Oxford, 
UK and known not to express any variant of STEVOR, was chosen for the 
study. The A4 strain was later transfected at Peter Preiser's lab with two 
different STEVOR genes PF10_0395 and PFF0850c to get A4 (tr-I) and A4 
(tr-II) clones respectively which could positively show STEVOR expression 
levels [109, 179]. Thus, in total, a set of four parasite clones were used in the 
study - 5A (obtained by limiting dilution of 3D7 strain), A4 strain, A4(tr-I) 
and A4(tr-II). 
2.2.3  AFM based Force mapping technique 
Atomic force microscopy (AFM), a subset of scanning microscopy techniques, 
utilizes a simple mechanical probe to scan the surfaces at ultra high resolution 
and extracts useful information about various surface properties of the sample. 
One of the best merits of AFM is that it does not require any kind of 
modification or treatment on part of the sample. Hence, it is also capable of 
taking measurements under physiological conditions thus protecting the native 
state of biological entities. In this technique, a laser probe is directed at the 
flexible cantilever tip and the tip is scanned against the sample surface. The 
reflected laser light from the tip probe is positioned on a four panel diode 
surface. During the scan, the deflection of the cantilever is measured as the 
shift in the position of the reflected laser light on the diode surface which is 




sample surface [110]. For small deflections, the behaviour of the cantilever 
can be approximated as a Hookean spring and thus very small forces (in the 
range of pN) can also be measured with great accuracy with this approach 
(Figure 2.1). 
The potential of atomic force microscopy (AFM) to measure and quantify 
inter-molecular forces in different ligand-receptor pairs down to pN range has 
been well demonstrated [111-115]. This force mapping approach has been 
well exploited for molecular recognition purposes by functionalizing the AFM 
tip with antibody molecules targeted against the molecule of interest. 
Integration of spacer technology further improves the motility and flexibility 









Figure 2.8: Schematic of the Atomic Force Microscopy (AFM) [138] 
 
unbinding events [116-120]. With the simultaneous measurement of surface 
topology and adhesive interactions in different environments [123], binding 
sites of molecules can be mapped to their positions on substrate surface with 




mapping technique has been used before to recognize different biotin-avidin 
pairs [112, 114], antibody-antigen pairs [116, 118-120], cell recognition 
proteins [125], DNA bases [124], etc. The first malaria-related application of 
AFM focused simply on the morphological scan of the iRBC [126]. Since 
then, significant improvements in protocols have led to new findings revealing 
various topological features on malaria iRBCs in different species of the 
Plasmodium parasite [127-130]. The force mapping mode in the AFM is one 
of the most useful tools to perform visual-quantitative studies at nanoscale 
precision. Along with morphological information, this mode enables to extract 
the mechanical properties and dynamic responses from molecules on the 
surface of the sample [119, 120]. 
In this study, AFM tips were functionalized with anti-STEVOR antibodies and 
probed against iRBCs from above clones (Figure 2.2). Adhesive molecular 
interactions resulting from probing experiments were processed to characterize 
the STEVOR expression and distribution on surface of late stage iRBCs. 










2.3  Experimental methods and designs 
2.3.1 Parasites and cultures 
Parasite clones were produced and collected as described in earlier works 
[109, 179]. Parasites were cultured in vitro in human RBCs suspended in 1X 
1640 RPMI (Invitrogen) supplemented with Albumax I (Invitrogen), 2 mM L-
glutamine, 50mg/ml hypoxanthine and 25mg/ml gentamycin at 2.5% 
hematocrit and incubated in an atmosphere of 3%O2, 5%CO2 and 92%N2. Late 
stage infected cells from culture were enriched by Magnetic Assisted Cell 
Sorting (MACS, Miltenyi) setup. The enrichment efficiency was quantified by 








2.3.2  Antibodies and transfected clones 
Anti-STEVOR antibodies and A4 transfected clones were developed and 
characterized in our collaborator Prof. Peter Presier's lab at Nanyang 
Technological University, Singapore.  
For antibodies, briefly, polyclonal antibodies S1 and S2 were raised in rabbit 
against the conserved regions of the two genes PF10_0395 and PFF_0850c. 




These antibodies were designed in order to recognize the maximum number of 
STEVOR variants and hence the semi conserved region was used as the target 
epitope. The specificity of the developed antibodies against STEVOR proteins 
was validated by Western blot data. The details regarding the generation of 
antibody and its specificity tests have been described elsewhere [109, 179]. 
Antibodies against the intracellular ATS domain of PfEMP1, used as a 
negative control to the surface probing on iRBCs, were also obtained from 
Prof. Peter Preiser's lab. 
To get A4 transfected clones A4 (tr-I) and A4 (tr-II), PFF_0850c and modified 
PF10_0395 STEVOR genes were cloned, respectively into the pARL vector 
and selection was carried out using 5nM WR992910. Resistant parasites were 
first seen in blood smears between 28 and 35 days post-transfection. The 
transfectants were evaluated by RT-PCR and IFA for expression of exported 
STEVOR proteins. Full details of transfection and validation experiments can 
be found in [179].  
2.3.3  Characterization of clones 
Before performing any of the experiments in our work, all clones were 
characterized using live immunofluorescence assays (IFA) in our lab for 
STEVOR expression. For IFA assays, iRBCs from clones 5A, A4 & A4(tr-I & 
tr-II) were enriched by magnetic purification (MACS), fixed with 4% 
paraformaldehyde for 15 minutes, permeablized with 0.05% Triton X100 
(Sigma-Aldrich) and resuspended in 1%BSA in PBS. After incubating with 
BSA, the washed pellets from all clones except A4 (tr-II) were incubated with 




unbound antibody was removed by washing the suspension 3 times with 1X 
PBS. Primary antibody was detected by incubation for 1 hour with anti rabbit 
serum (1:500) conjugated to Alexa 488 (for A4 (tr-I) clone) or PE (for 5A 
clone) (vCell Science). For A4 (tr-II) strain, no staining with antibodies was 
performed. Before imaging, samples from each clone was briefly stained with 
4, 6-diaminido-2-phenylindole (DAPI, 2 mg/mL in PBS) followed by wash in 
1X PBS. Slides were mounted in VECTASHIELD (Vector Laboratories) and 













Figure 2.11: IFA imaging of clones. Fluorescence images of different clones 
conjugated with anti-S1 serum (5A, A4, A4(tr-I)). A4(tr-II) clone contains 
GFP tagged STEVOR proteins. For 5A, the primary antibody was detected 
with PE conjugated goat anti-rabbit serum and for A4(tr-I), Alexa-488 
conjugated donkey anti-rabbit serum was used as the secondary antibody. 
Successive columns from left to right show the bright field, DAPI, STEVOR 
staining and merged images. A4 clone does not exhibit any staining with 




2.3.4  Substrate preparation for AFM experiments 
13 mm cover slip substrates were coated with lectin molecules which strongly 
bound to carbohydrate molecules and glycoproteins on the cell surface. The 
glass substrates were first cleaned by plasma treatment (Harrick Plasma). 
PhAE solution (Sigma Aldrich) in 1X PBS was then coated over the cleaned 
cover slips and cover slips were then incubated at room temperature for 20 
minutes. 
2.3.5  Cell sample preparation 
The enriched cells were incubated with PhAE coated cover slips for around 15 
minutes at room temperature. The free or loosely bound cells were washed off 
by rinsing in malaria culture medium thrice. 
2.3.6  AFM tip functionalization 
The protocol used to functionalize the tips in our study was similar to the one 
used in [131]. Fresh MLCT model AFM tips (Veeco Instrument) were cleaned 
in ozone plasma for half an hour (Harrick Plasma). The cleaned tips were 
incubated with 1mg/ml BSA-Biotin overnight in a parafilm sealed petri dish at 
4ºC. Next day, the tips were washed 3 times in distilled water and incubated 
with streptavidin for 30 minutes at room temperature (RT) followed by gentle 
wash with distilled water and incubation with 1mg/ml NHS-PEG4-Biotin 
linker (Thermo Scientific) for 30 minutes. The PEG linker was used to 
increase the separation between the AFM tip surface and the target protein 
molecules expected to be exposed on the membrane of iRBCs, thus 
significantly reducing the percentage of non-specific adhesive interactions 




incubated with rabbit anti STEVOR antibodies (1:200) for around 90 minutes. 
Finally, the tips were treated with 1mg/ml glycine in PBS solution (Sigma-
Aldrich) for another 30 minutes to quench free activated amino groups. After 
gentle wash with distilled water for 3 times, the tips were ready to be used 
immediately. 
2.3.7  AFM tip functionalization - validation of protocol 
The antibody functionalization protocol of AFM tips was validated by 
confocal microscopy. The functionalized tips which had already been used for 
force mapping experiments on AFM set up, were incubated with anti rabbit PE 
conjugated secondary antibody (Santa Cruz Biotechnology, Inc.) for 60 
minutes at room temperature. Tips were then washed three times using 1X PBS 
and imaged on the confocal microscope (ZEISS). Fluorescence imaging was 
carried out at 488nm (excitation wavelength) and 559nm (emission 
wavelength) under 63X magnification objective. The lens was moved in the z-
direction and the view plane where fluorescence was first spotted was chosen 
as the initial layer for 3D reconstruction. The lens was then continuously 
moved in the same direction till the fluorescence intensity reached to 
minimum value again. This plane was selected as the last layer in the 3D 
stack. The entire stack in z-direction was divided into 60 layers and scanned to 
obtain the final 3D reconstruct of the tip. 
2.3.8  AFM set up 
For each experiment, the prepared cover slip with coated cells was glued to the 
base of an empty and pre-cleaned 35 mm petri dish using suitable glue. The 




BSA solution was also added to suppress the non-specific interactions during 
the experiment. The petri dish was mounted on the microscope stage 
(Olympus) assembled with the NanoWizard II AFM set up (JPK Instruments). 
Prior to experiment, target late stage iRBCs were viewed through 60X 
objective lens in the brightfield mode to get a visual confirmation on the stage 
of infection by identifying the hemozoin that were seen as black dots inside 
the cells (Figure 2.5).  
 
Figure 2.12: Adhered late stage iRBCs on PhAE coated cover slip 
 
All AFM imaging and force mapping experiments were carried out on the JPK 
AFM-Confocal set up in a fluidic environment at room temperature (Figure 
2.6). For all experiments, triangular silicon nitride cantilevers with spring 
constant of 0.01N/m were used. The AFM tip functionalized with STEVOR 
antibody was mounted up on AFM tip holder and a drop of 1X PBS solution 
was dropped onto it to wet the tip completely. This was done in order to avoid 




fluid. Next, the AFM head was mounted up on the microscope stage. The up 
and down movement of the tip was regulated by three servo motors attached in 
the base of the AFM head which were controlled precisely through the JPK 
software. The AFM head was brought down incrementally so that the tip was 
fully dipped inside the liquid solution but was still quite far from the surface of 
the cover slip. The laser beam was aligned on the head of the cantilever and 
mirror angle was adjusted to yield the maximum possible sensitivity on the 
detection panel. Just before each scan, the horizontal and vertical deflections 








Figure 2.6: Image of entire AFM set up, with highlighted AFM head and 
microscope. The AFM head is mounted on a customised stage which is 
integrated with the microscope. The microscopic zoom in view of sample area 
shows the AFM cantilever and adhered iRBCs and uRBCs. 
 
 
2.3.9  Calibration of AFM cantilever 
Calibration of the AFM cantilever involved two parts - calibration of its 
sensitivity, i.e., converting voltage signals into force and height scale, and 




In order to calibrate the sensitivity of the functionalized cantilever, a typical 
set point voltage was first set and the cantilever was indented against the hard 
substrate. The slope of the indentation part in resulting force curves provided 
the sensitivity of cantilever in V/m. This was repeated a few times till a 










Figure 2.7: Screenshot of a typical sensitivity measurement graph. Green 
colour shows the approach force curve and blue colour is retraction force 




For calculating the actual spring constant, the cantilever was retracted back 
sufficiently far away from the substrate but was still kept submerged in liquid. 
The inbuilt thermal tuning algorithm in JPK software was used to get the 
resonant frequency and spring constant of the freely vibrating cantilever 







Figure 2.8: Screenshot of the thermal vibration spectrum of the cantilever. 
Different parameters calculated by the algorithm are shown in the inset box. 
Spring constant of the cantilever spring was calculated to be around 0.01N/m 
by the algorithm which is close to the commercial value on the cantilever box. 
 
2.3.10  Force mapping parameters: 
All force scans were performed at 64 X 64 pixels resolution with tip approach 
speed of 20μm/sec. The set point force was maintained between 50-100pN to 
ensure the proper contact between the tip and the target iRBC. A delay period 
of 50 ms was set to ensure sufficient time for adhesive interactions to occur 
between molecules of interest, if any. The data capture frequency was set at 
9000Hz. The z-range movement of the piezo was kept at a maximum of 15μm 
to cover all possible height variations during the scan. Other feedback 
parameters were adjusted accordingly to get best possible control on piezo 
movement. The resulting force curves and adhesion events for each extension-





2.3.11  Force mapping experiments 
Probing experiments were performed to compare the force map scan response 
of adhered late stage infected RBCs with functionalized and non-
functionalized or bare tips. Scan area was kept fixed at 8 X 8μm with a spatial 
resolution of 64 X 64 pixels and scanning was carried out in contact mode in 
fluidic environment. The adhered infected RBCs on the substrate in a given 
view field were first scanned using the anti-STEVOR antibody functionalized 
tip. The functionalized tip was then replaced by a bare tip of identical 
parameters and same cells were scanned using the bare tip. Since the cells 
were pre-fixed, the protein expression and parasite stage modifications were 
not the issues of concern. The force-image data obtained with both types of 
tips were stored and processed later to compare the tip-cell surface interactions 
in both cases. All other experimental parameters were kept identical for both 
conditions.  
2.3.12  Control experiments  
Various control experiments were performed to filter out the background noise 
and non-specific interactions that could interfere with the relevant force data. 
Out of entire control set, two sets of control experiments which were recorded 
in details were - bare tip & PhA-E coated glass surface (to minimize 
background noise) and functionalized tip & uRBCs (to avoid non-specific 
interactions).  
The first set of control experiments was carried out to characterize the 
background noise between bare tip and empty PhAE coated glass surface. The 




the background noise data was collected. This was repeated for 5 different 
cover slips with 10 different scan areas on each. 
In the next set of control experiments, force mapping was performed between 
functionalized tip and uninfected RBCs in the sample and force curves were 
collected. Data was collected and analysed for 5 different cover slip samples 
with 10 uRBCs on each. 
2.4  Data processing 
Force curve analysis: 
When a bare tip was tested on PhAE coated glass surface, typically a sharp 
transition from horizontal line to a linear slope was seen, indicating the contact 
point in approaching phase. Retraction trace in some of the curves showed 
small rupture peaks indicating some non-specific interactions classified as 
"background noise" (Figure 2.9(A)).  
When a functionalized tip was scanned on uninfected cells, approaching trace 
was similar to a typical soft substrate approach with a smooth transition from 
the horizontal line to a linear slope. The retraction phase revealed rupture 
peaks indicating some "non-specific interactions" (Figure 2.9(B)).  
Force map scanning of iRBCs with a non-functionalized or bare tip, in 
general, also produced a typical approach trace as with normal cells. The 
retraction curves showed mostly "quiet" force traces. However, some spots of 
"non-specific interactions" could be observed with some cells (Figure 2.9(C)). 
When a functionalized tip was tested on iRBCs, retraction trace showed 




peak. At some occasions even multiple ruptures were also observed. This 
behaviour varied from one iRBC to the other depending on the stage of 
infection (Figure 2.9(D)).  
Figure 2.9: Example force curves for different combinations of tip 
functionalization and target substrate. (A) Bare tip - PhAE coated glass 
surface, (B) tip functionalized with anti-STEVOR antibody - uRBCs adhered 
on PhAE coated glass surface, (C) bare tip - asexual stage iRBCs adhered on 
PhAE coated glass surface, (D) anti-STEVOR antibody functionalized AFM 
tip - asexual stage iRBCs. 
 
Force curves from all control experiments were processed using various 
inbuilt algorithms in JPKSPM software (JPK Instruments). Force curves 
distorted due to some thermal fluctuation or other external disturbances were 
excluded and only standard shaped curves were included in data analysis. For 
all experiments, only the retraction force curve for each cycle was processed 




during the retraction of the tip from the cell surface. All sorted force curves 
were processed using the following sequence of operations: 
1. smoothening : In order to remove the thermal fluctuations and background 
noise, the force curves were smoothened out using the low-pass filter in the 
JPK processing software. 
2. offset elimination : In order to get the cell surface height profile, alongwith 
quantitative adhesive information, all the force scans were performed in 
relative mode of force mapping. So, the contact point on each force curve 
might not be necessarily at zero force value. In order to standardize all force 
curves and set the tip-sample contact point at zero contact force, the offset in 
vertical force was eliminated in each curve. 
3. Minima extraction : For force curves from control experiments, the point 
with lowest y-coordinates on the retraction force curve of the scan was 
selected as the maximum non-specific adhesion force between the tip and the 
surface. For force curves from cell probing experiments, the bond rupture 
points were extracted manually from each retraction force curve. 





Figure 2.10: The sequence of operations applied on raw force curves to 
extract the background and non-specific interactions. The first operation was 
performed to remove the extra noise from the force signal and smoothen out 
the force curves. Offset elimination was performed to remove the offset in the 
contact point force and bring it to zero. Minima extraction was done to get the 
maximum adhesion force point on the force curve (region highlighted in blue) 
during the retraction of the tip from sample surface. 
 
The set of control experiments performed with functionalized tip and PhAE 
coated cover slip surface was used as a filter to eliminate background noise 
from force curve obtained from all sets of experiments. And, other sets of 





Based on the threshold values for background noise and non-specific 
interactions, the force curve processing model was further modified to extract 
only the relevant bond breaking events, with rupture strength greater than the 
thermal noise based threshold. The force curves obtained from experiments 
with functionalized tips and iRBCs were processed using the updated model. 
2.5  Results and discussion 
2.5.1  AFM tip functionalization 
The AFM tips were functionalized using the protocol as described in sections 
earlier. Anti-STEVOR antibody molecules were attached to the tips via steps 
of covalent bonding. Being chemically inert, flexible PEG linker molecules 
allowed functionalized STEVOR antibody molecules to freely reorient and 
bind with the target protein molecules [132]. Figure 2.11 shows the 3D 
confocal images of a freshly prepared STEVOR antibody functionalized AFM 
cantilever labelled with PE conjugated secondary antibodies. As it can be 
clearly seen from the figure, the entire cantilever as well as the pyramid 
shaped tip is fully covered with STEVOR antibody molecules. These results 
confirmed that the protocol used was able to successfully adsorb antibody 
molecules onto the AFM tips through specific surface conjugation methods 






Figure 2.11: 3D Confocal images of the functionalized AFM tip from 
different angles. Bright red colour shows the PE conjugated secondary 
antibody molecules bound to anti-STEVOR primary antibody immobilized to 
the cantilever surface. 
 
2.5.2  Control experiments - Noise and non-specific filtering 
For experiments with functionalized AFM tips, to ensure that only the specific 
adhesion events resulting from actual protein-antibody interactions were taken 
into account for data processing, force curves from control experiments were 
carefully processed and threshold values were set on the detachment force 
magnitude obtained from the retraction curves. The force curves obtained 
from experiments with bare tips and PhAE coated cover slip surfaces were 
processed using the sequence of operations as described in methods section. 
30 individual force-frequency histograms obtained from different cell scans 
were binned together to get the mean histogram of background interactions 
(Figure 2.12). The peak of the histogram was found to be at 9pN and 
approximately 99.4% of the molecular interactions had detachment force value 
less than or equal to 15pN. So, 15pN was set as the final cut-off threshold to 











Figure 2.12: Force-frequency histogram of the background interactions. 
Dotted line shows the Gaussian fitting curve. 
 
Same procedure was followed for the other set of control experiments. Control 
experiments with functionalized tips-uRBCs were performed as a pre-filtering 
set for the actual force interactions study between iRBCs and functionalized 
tips. This was done to rule out the possibility of any kind of non-specific 
interactions that the functionalized tip might have with any 
other protein on the uRBC membrane surface. Individual force-frequency 
curves were obtained by scanning 30 uRBCs for each of the cases and were 



















Approximately 99.6% of the interactions were contained 
 in the bound of 18pN. So, 20pN was set as the lower cut-off threshold for 
"bond rupture value" in the retraction trace of force curves obtained from 
functionalized tip-iRBCs interactions. Few interactions which were observed 
to have occurred between some debris lying on the surface of the uninfected 
cell surface and the tip were found to have detachment force value higher than 
20pN threshold. Such interactions were classified as outliers and were rejected 
from further analysis. 
Table 2.1 shows the summary of all control experiments performed. 
 
 
Figure 2.13: Force-frequency histogram of non-specific interactions. 




Table 2.1: Description of various control experiments. First column shows the 
molecules immobilized on the tip, second column indicates the target being 
probed by the tip and the last two columns show the outcome summary of that 
particular control experiment. 








99.4% interactions < 
15pN detachment force  
 (background noise 
threshold set as 15pN) 
anti-S1 
serum 
uRBCs 99.6% interactions < 
18pN detachment force 
 (non-specific threshold 
set at 20pN) 
Fresh iRBCs 
(5A) 







4.6% interactions > 
20pN 
Negative control with 





4.2% interactions > 
20pN 
Negative control to 
ensure surface probing 
 
2.5.3  STEVOR recognition - probing with bare vs. functionalized tip 
To test the presence of STEVOR proteins on iRBC surface, protein-antibody 
affinity based comparative molecular force spectroscopy was employed, 
wherein, late stage iRBCs from 4 different clones were separately probed with 
BSA coated tips (bare tips) and anti-STEVOR antibody functionalized AFM 
tips (functionalized tips). The adhesive interactions between tips and iRBCs 
were quantified in terms of force-frequency histograms and adhesion force 
maps. STEVOR proteins, if exposed on the extracellular surface of iRBCs, 
would yield more broadly distributed force spectrums with distinctly higher 
bond rupture force values, when probed with functionalized tip as compared to 
probing with bare tip. Figure 2.14 shows the force frequency histograms 




bare tip. As can be clearly observed, the two force-frequency histograms are 
significantly different in terms of adhesion distribution densities and 
detachment force values.  
As summarized in the inset table, during scanning with bare tip, 93.1% of the 
adhesion events between the tip and the example cell had detachment force 
values of 0-20pN which overlapped with the background and non-specific 
noise regimes. On the other hand, a highly distributed force spectrum 
comprising of 96.8% specific adhesion events (events with detachment force 
value above the background noise threshold) were obtained with the iRBC 














Figure 2.14: Raw force-frequency histograms when an iRBC was probed 
separately with functionalized tip & bare tip. 93.13% molecular interactions 
with bare tip are in 0-20 pN as indicated by the arrow. The inset table shows 




Same set of AFM probing experiments were also performed under identical 
conditions with the three clones - 5A, A4 (tr-I) & A4 (tr-II), 20 late stage 
iRBCs from each clone. Mean cumulative adhesion frequency - cumulative 
sum of force bin-wise population averages of percentage of molecular 
interactions, for all 60 iRBCs was plotted in both cases as shown in Figure 
2.15.  
 
As evident from the inset scatter plot, only about 3.8% of the occurring 
molecular interactions had their detachment force value above the background 
Figure 2.15: Comparison of mean cumulative adhesion frequncies (including 
the background overlap range of 0-20pN) obtained from dual probing 
experiments on dataset of total 60 iRBCs. These total 60 iRBCs represent 3 
groups of 5A, A4(tr-I) and A4(tr-II) with 20 cells from each strain. The inset 
graph shows the scatter plot distribution of % specific molecular interactions 
(with detachment force value > background threshold) for all 60 iRBCs in 
both probing scenarios. Each scatter point shows the response from individual 
iRBC, lower & upper box limits represent 25th & 75th percentile respectively 




threshold (defined as specific adhesion frequency). On the other hand, about 
59.9% of the interactions were observed with detachment force higher than 
background threshold when same set of iRBCs were probed with 
functionalized tips. In the latter case, the values for individual cells varied 
from 27.8% to 91.6% depending on the stage of infection and the type of 
clone.  
Adhesion frequencies amongst different clones have been compared in Figure 
2.16. Transfection of A4 clone with STEVOR genes significantly increased 
the occurrence of observable rupture force related adhesion events as was 
evident from the 52.1% and 67.4% specific adhesion frequency in A4(tr-I) and 
A4(tr-II) clones, respectively, as opposed to just 4.6% in A4. This clearly 
demonstrated the surface trafficking of STEVOR molecules and subsequent 








Figure 2.16: Scatter plot distribution of specific adhesion frequencies 
obtained when different clones - 5A, A4 & A4(tr) were probed with 
STEVOR antibody functionalized AFM tip. 5A clone probed with anti-ATS 
antibody functionalized tip has been shown as a negative surface control. 
Each data point represents frequency level in one iRBC, upper & lower box 
boundaries are 25th & 75th percentile respectively and whiskers represent 




As a negative control, probing of 5A parasites using AFM tips functionalized 
with anti-ATS antibbody, directed against the cytoplasmic domain of PfEMP1 
proteins, was carried out under identical conditions. This also allowed 
validation of the range of force mapping parameters and ensured that only the 
extracellular surfaces of cells were examined. From the graph, only 4.2% of 
de-adhesion interactions with anti-ATS functionalized tip were observed to 
occur above the 20pN rupture force threshold and was similar to interactions 
of A4 with STEVOR-Ab functionalized tip and interactions between 5A and 
bare tip. As the % occurence of specific adhesion events directly correlated 
with the amount distribution of STEVOR protein molecules on the cell 
surface, these results provided direct evidence that the STEVOR proteins get 
exposed on the extracellular surface of the iRBCs during late stages of asexual 
life cycle of the parasites. 
2.5.4  Stage wise comparison of STEVOR expression 
To analyse the surface expression levels of STEVOR proteins in a stage-
dependent manner, the entire set of force scans from 5A, A4 (tr-I) and A4 (tr-
II) populations were grouped into the trophozoite and schizont stages. To 
complete the full blood stage life cycle analysis, a separate set of force 
mapping experiments were carried out with 20 ring stage iRBCs (10 from 5A 
clone and 5 each from A4(tr-I) and A4(tr-II)).  
Figure 2.17 shows compilation of different iRBCs at different progressive 






The adhesion force maps reflected the change in the distribution density of 
adhesion events and associated detachment force values. For quantitative 
analysis, the detachment force values in force-frequency histograms obtained 
from scanning experiments were categorized into four major bins - 0-20pN, 
20-100pN, 100-500pN and >500pN and values were compared (Figure 2.18). 
Table 2.2 shows the percentage of molecular interactions in each of the bins 








Figure 2.17: First row shows the AFM reconstructed images of different 
iRBCs in progressive asexual stages, second row shows the corresponding 
adhesion maps generated by force probing cell surfaces with functionalized 
tips. Colour spots in adhesion map depict the strength of adhesion at that spot. 
Figure 2.18: Force-bin wise distribution of mean adhesion frequencies for 
iRBC populations of three different stages. Error bars represent the 




Table 2.2: Comparison of adhesion frequency in different asexual stages 
 
In summary, the cumulative specific adhesion frequency, i.e., the cumulative 
percentage of molecular interactions above the threshold rupture value, in each 
stage was observed to increase from 8.1% (ring) to 53.6% (trophozoites) and 
to 88.63% (schizont) (Figure 2.19). This clearly reflected a consistent increase 
in the surface expression levels of STEVOR proteins on iRBCs surface as the 










Adhesion frequency (%) 
uRBCs Ring Trophozoite Schizont 
0-20 98.43 91.86 46.41 11.37 
20-100 1.16 7.93 34.9 69.39 
100-500 0.41 0.19 13.489 14.18 
>500 0 0.02 5.201 5.06 
Figure 2.19: Cumulative specific adhesion frequency (cumulative % sum of 
all specific adhesive interactions) in population sets of uninfected, ring, 
trophozoite and schizont RBCs. Data represents the mean ±SEM for each 




2.5.5  An alternate architecture model for STEVOR  
STEVOR is one of the major variant antigen families of P. falciparum. Earlier 
predictions using different bioinformatics software claimed that the STEVOR 
proteins have a 2TM domain structure [133]. As such, the semi-conserved 
region of the STEVOR proteins has been predicted to be intracellular, with the 
hyper variable region exposed as a loop on the extracellular side of the 
membrane.  
The anti-STEVOR antibodies, used as a probe in our force mapping 
experiments with iRBCs, were developed against the semi conserved region of 
the protein family as target epitopes. Significant differences in adhesion 
strength observed with the bare AFM tips versus the functionalized tips 
suggested that the recognition between antibody and the protein target domain 
is highly specific. High percentage of adhesion events with two different 
STEVOR genes proved that the semi conserved region of the protein is 
exposed on the extra-cellular surface of iRBC membrane. This data challenges 
the previously predicted 2TM domain structure and instead suggests that the 
protein has a single TM domain structure with both, the semi conserved and 
hyper variable regions of the protein exposed on the extracellular side of the 





2.6  Discussion 
Results from our AFM experiments suggest that STEVOR begins to appear on 
the iRBC surface from the trophozoite stage (~22 hour post infection) 
onwards, which is consistent with earlier transcription profiling data [134-
136]. We also observed that the surface expression of STEVOR constantly 
increases up till the mature schizont stage. The systematic export of different 
antigen groups in a tightly regulated timely manner may be of crucial 
significance in disease pathology. Earlier studies have shown that PfEMP1 
gets exported to the surface as early as 16 hours post infection [133, 137]. The 
delayed export of STEVOR on the iRBC surface after PfEMP1 may provide 
an interesting insight into the time dependent interplay between protein export 
machinery of the parasite and the adhesion phenotype exhibited by the 
parasite. It is likely that PfEMP1, with a variety of binding domains for 
Figure 2.20: Left model shows the conventional 2TM domain structure of 
STEVOR proteins as predicted by earlier theoretical predictions with semi-
conserved domain in the intracellular region of iRBC. The right structure 
shows the proposed 1 TM domain architecture model for STEVOR based 
on our experimental findings. Semiconserved domain and hypervariable 




endothelial receptors, appears first on the surface in order to enable the 
parasite to sequester within the microvasculature. The subsequent export of 
STEVOR can help parasite to develop new pathways for immune avoidance 
and successful completion of asexual life cycle. Antigenic variation and 
rosetting may be two of the possible mechanisms by which surface exposed 
STEVOR antigens may be utilized by the parasite.  
Antigenic variation may be quite important at late asexual stages when the 
iRBCs are sequestered in deep vascular sites. Within these sites of 
sequestration, iRBCs remain exposed to the host immune system for a period 
of more than 24 hours. During this time, the host immune system can mount 
an effective adaptive immune response using antigens on the surface of these 
sequestered iRBCs as targets. Creating an additional source of antigenic 
variation by exporting variant STEVOR antigens to the iRBC surface may 
directly enhance the immune evasion ability of the parasite, thus enabling it to 
safely reach maturity before bursting. However, lack of sufficient evidence 
thus far in support of this hypothesis, makes it an interesting avenue for future 
investigations. 
Alternatively, STEVOR may also be involved in mediating the formation of 
robust rosettes on these sequestered late stage iRBCs. Recent studies have also 
shown direct correlation between STEVOR expression and rosetting ability of 
parasites [179]. Detailed discussion about this topic will be carried out in 








Spatial characterization of surface exposed 
STEVOR proteins 
 
3.1  Preview 
This chapter describes the experimental studies performed to study the  
patterns of distributions of STEVOR molecules on the late stage iRBC 
surface. AFM experiments in this part of the work were started in 
collaboration with Kripa Madnani, NTU. 
First, we will describe the details of nanoimaging techniques - immunogold 
(IG) SEM and TEM, employed to study and characterize the distribution of 
STEVOR molecules.  
Next, we will talk about the detailed protocols and optimization strategies to 
prepare samples and perform SEM and TEM experiments. 
Then, we will present the results from the set of AFM force mapping 
experiments that were performed to study the distribution patters of STEVOR 
on the iRBC surface and test if these molecules were forming clusters. 
Next, we will proceed to present the findings from our IG-SEM and IG-TEM 





Finally, based on these results, we will characterize the STEVOR distribution 
patterns on the surface of late stage iRBCs. 
3.2  Introduction 
3.2.1  Background 
The detailed spatial distribution of STEVOR proteins was studied using two 
different approaches - AFM force mapping of zoom in areas on surface of 
schizont stage iRBCs and IG-SEM and IG-TEM techniques. Details of AFM 
and force mapping mode were mentioned in previous chapter. Here, we will 
describe the additional techniques used to analyze the distribution patterns of 
STEVOR proteins. 
3.2.2  ImmunoGold Transmission Electron Microscopy (IG-TEM) 
3.2.2.1  TEM - basic principle 
The transmission electron microscope (TEM) is a very powerful tool for 
imaging the biological structures. A high energy beam of electrons is passed 
through a very thin sample and the interactions between the incident electrons 
and atoms helps the sample features to be projected on a fluorescent screen. 
The basic operating principle of the TEM is identical to light microscopy, only 
difference being that it utilizes the electron particles to produce an image of 
the sample section being examined. Because the wavelength of electrons is 
much smaller than that of light, the optimal resolution attainable for TEM 
images is many orders of magnitude better than that from a light microscope 




Figure 3.1 shows a simple sketch of the path of a beam of electrons in a TEM 
from just above the specimen and down the column to the phosphor screen. As 
the electrons pass through the sample, they are scattered by the electrostatic 
potential set up by the constituent elements in the specimen. After passing 
through the specimen they pass through the electromagnetic objective lens 
which focuses all the electrons scattered from one point of the specimen into 
one point in the image plane.  
3.2.2.2  IG-TEM - background 
Immunoelectron microscopy is one of the best methods for detecting and 
localizing proteins in cells and tissues. It has been an important tool in cell 
Figure 3.13: General layout of a TEM describing the path of electron beam in a 




biology for many decades, supplying powerful, highly valuable visual 
evidence to help reveal the specific localization of cell proteins, which 
consequently allows different cellular types to be identified. In addition, the 
knowledge concerning the sub cellular immunogold localization of a wide 
range of proteins has given novel information on structure-function 
relationships and enhanced the understanding of the cell biology in various 
physiological and pathological conditions [140-144]. The use of primary 
antibodies conjugated with gold particles allows high resolution detection and 
localization of a multiplicity of antigens, both on and within the cells.  
3.2.2.3  Protocols in IG-TEM 
The two following general approaches are applied to localize cell antigens 
[145]: 
- When the interest is focused on identifying cell surface proteins, the pre-
embedding labelling protocol is the most convenient as antigens and ultra 
structure are well preserved by this method. 
- When the objective is to localize the intracellular antigens, there are at least 
three different protocols that can be used: post-embedding, after embedding in 
acrylic resins; cryo-ultramicrotomy in tissue sections obtained without 
embedding, and pre-embedding combined with membrane permeabilization. 
 (A)  Pre-embedding technique 
The pre-embedding method is applied to perform immunogold labelling 




samples (e.g. brain tissue), thus resulting in a greater preservation of the 
antigenicity of the molecules [148, 149]. 
One of the main advantages of this approach is that specimens are not exposed 
to harmful or possibly damaging chemicals that can lead to the blocking or 
loss of target proteins. In addition, after performing immunolabeling, the 
samples are processed for conventional electron microscopy and included in 
epoxy resins that allow an improved preservation of the cellular ultra-
structure. This technique enables the immuno detection of antigens on the 
surface of isolated cells, viruses or bacteria, with gold particles being localized 
not only on the cell surface but also on membrane extensions (pili, flagella) 
[150, 151]. 
(B)  Post-embedding technique 
The post-embedding technique is a good alternative to produce contact 
between the antibodies and internal antigens exposed at the surface of thin 
sections obtained from resin embedded tissues [146, 147]. By using this 
procedure, specimens are first embedded in resin and sectioned at 60–90 nm. 
However, post-embedding immunocytochemistry has its own limitations, with 
the main drawback being that antibodies cannot penetrate into the resin, and 
consequently only the antigens that are exposed at thin section surfaces can be 
labelled. In addition, antigens are affected by fixatives, solvents, resins and 
heat during polymerization, thus compromising antigenicity. Nevertheless, 
each of these “threats” to antigenicity can be avoided, at least in part, by 




electron microscopy related to fixation, dehydration, inclusion media, and 
temperature [145].  
3.2.3  ImmunoGold Scanning Electron Microscopy (IG-SEM) 
3.2.3.1  SEM - basic principle 
The scanning electron microscope (SEM) uses a focused beam of high-energy 
electrons to generate a variety of signals at the surface of solid specimens 
[152]. The interactions between the sample surface and incident electrons 
produce a variety of signals comprising of secondary electrons (that produce 
SEM images), backscattered electrons (BSE), diffracted backscattered 
electrons (EBSD that are used to determine crystal structures and orientations 
of minerals), photons (characteristic X-rays that are used for elemental 
analysis and continuum X-rays), visible light (cathodoluminescence–CL), and 













Secondary electrons and backscattered electrons are commonly used for 
imaging samples. Secondary electrons are most valuable for showing 
morphology and topography on samples and backscattered electrons are most 
valuable for illustrating contrasts in composition in multiphase samples. 
3.2.3.2  IG-SEM - Background 
Scanning electron microscopy is a useful technique that can be used to image 
the surface of whole organisms, tissues, cells, cellular components and 
macromolecules. A high range of magnification possible (up to ×1,000,000) 
in this methodology allows a huge variety of biological processes and 
structures to be imaged at the resolution of interest. Any surface that can be 
exposed can potentially be studied in this way. In order to identify a protein of 
interest at high resolution, or to quantify its distribution at lower 
magnifications, samples can be labelled with antibodies [154, 155]. Following 
the seminal work on discovery of gold colloidal particles as conjugated 
markers [157], a number of studies have utilized this approach of labelling 
proteins and structures. These small nanoparticles (5-15nm) are coupled to a 
secondary antibody to identify antigenic sites on biological surfaces and can 
be detected in highly sensitive back scattered signal [156-159]. Set of SEM 
techniques; therefore represent important and useful tools facilitating the 







3.3  Experimental materials and methods 
3.3.1 Parasites and cultures 
Parasite clones - 5A, A4, A4 (tr-I) and A4 (tr-II), as described in chapter2 
were used in this part of the study as well. Parasites were cultured in vitro in 
human RBCs suspended in 1X 1640 RPMI (Invitrogen) supplemented with 
Albumax I (Invitrogen), 2 mM L-glutamine, 50mg/ml hypoxanthine and 
25mg/ml gentamycin at 2.5% hematocrit and incubated in an atmosphere of 
3%O2, 5%CO2 and 92%N2. Late stage infected cells from culture were 
enriched by Magnetic Assisted Cell Sorting (Miltenyi) setup. The enrichment 
efficiency was quantified by optical microscopy to be around 80-90%. 
3.3.2  AFM force mapping 
These AFM force mapping experiments were performed with certain 
modifications from the experiments described in chapter 2. First, a mature 
schizont cell was identified in live brightfield image on the set up. The iRBC 
was then scanned, as before, at 64 X 64 pixels spatial resolution with all other 
parameters identical to previous experiments. Dense areas of high adhesion 
events were analysed and one 1μm X 1μm region of interest was further 
scanned at 128 X 128 pixels at 10 times lower pulling speed. This same 
procedure was repeated and 15 such unit area regions of interest were scanned 






3.3.3  IG-SEM sample preparation protocol 
1. Magnetically enriched samples of late stage iRBCs were fixed with 4% 
PFA for 15 minutes at room temperature. 
2. The suspension was washed twice with 1X PBS at 600g for 5 minutes. 
3. The pellet was resuspended in rabbit anti-STEVOR antibodies (1:50) 
and incubated for around 60 minutes at 37ºC. 
4. The suspension was washed three times with 1X PBS at 600g for 5 
minutes. 
5. The pellet was further resuspended in goat anti-rabbit secondary 
antibodies (Ted Pella Inc.) conjugated with 10nm gold (Au) 
nanoparticles for about an hour at room temperature. 
6. The suspension was washed three times with 1X PBS at 600g for 5 
minutes. 
7. The pellet was then resuspended in 4% PFA for about 4 hours at 4ºC. 
8. The suspension was washed three times with 1X PBS at 600g for 5 
minutes, resuspended to 1ml final volume in 1X PBS and stored at 4ºC 
for further analysis in EM laboratory. 
9. At EM laboratory, next morning, the samples were first washed in 1X 
PBS at 3000rpm for 5 minutes for two times. 
10. 13mm diameter round cover-slips were dipped in 0.01% Poly-L-
Lysine (PLL) solution and were left to dry completely. 
11. A drop of cell suspension was dropped onto the cover-slips and left for 
10 mins so that the cells could adhere well on coated cover-slips. 
12. The samples were post fixed in 1% OsO4, pH 7.4 for 30 minutes at 




13. Cover-slips were then washed twice in de-ionized water for 10 minutes 
each. 
14. The samples on cover-slips were then dehydrated in ethanol series at 
room temperature: 
a. 50% ethanol   5 mins 
b. 75% ethanol   10 mins 
c. 95% ethanol   10 mins 
d. 100% ethanol   10 mins (3 changes) 
15. The samples were kept submerged in excess of absolute (100%) 
ethanol and transferred to the CPD030 Critical Point Dryer 
(BALZERS) (Figure 3.3). 
Figure 3.3: Critical Point Drying (CPD) set up. 
 
16. Critical Point Drying (CPD) procedure 




a. The CPD chamber was dried, filled with absolute ethanol and 
cooled down to 7ºC beforehand. 
b. Once the chamber reached the set temperature, the specimens 
were quickly transferred into it and the chamber was sealed 
tight. 
B. Fluid exchange 
a. Once the temperature reached 10ºC, the liquid was flushed out 
until the chamber was at least 75% empty of liquid. 
b. Next, liquid carbon dioxide was flushed in until the chamber 
was full in again. 
c. Both step a and b were performed in cycle for 6 times to drain 
out the ethanol leaving liquid carbon dioxide in the chamber. 
C. Heating Up 
a. The cooling mechanism was stopped and the chamber was 
heated up until the temperature reached 38ºC. 
b. Heated gas was flushed out by releasing the pressure valve 
slowly. 
c. The chamber was opened and "dried" specimens were 
retrieved. 
17. Carbon coating of samples 
Carbon coating of the fixed and dried samples was carried out on 
CTA005 sputter coater (BAL-TEC). The specimens were mounted 
onto the stub with carbon tape. Mounted specimens were coated with a 




number element for conductive coating of the sample surface. Carbon 
has the advantage that its atomic number is very low and therefore the 
gold label is very clearly distinguishable from other features in the 
BSE image. This has also been the most widely used approach for the 
localization of gold colloids <15 nm [156]. 
3.3.4  SEM imaging of cell samples 
For SEM imaging, the samples were mounted on the special specimen holder 
of the imaging set up and the chamber was closed (Figure 3.4). Ultra low 
pressure vacuum was created inside the chamber by pumping out the air 
through vacuum pumps which were controlled via a digital interface command 
program.  






Next, the accelerating voltage, beam diameter and other focusing parameters 
were optimized to obtain a clear overview of the specimen surface at low 
resolution of around 500X. Then, the surface was zoomed-in to image 
individual cells. 
3.3.5  Detection of gold labels on cell surface 
Traditionally, high-resolution topographic surface information is obtained by 
the secondary electrons (SE) created on the specimen surface at the point of 
impact of the scanning electron beam. And, most of the backscattered 
electrons (BSEs) are produced at the gold particles. They appear, therefore, as 
bright spots in the BSE image (Figure 3.5) [161, 162]. 
Figure 3.5: Schematic to demonstrate the interactions between the primary 
electron beam and a gold labelled and carbon coated biological specimen 
surface. 
 
The straightforward approach of the material-dependent BSE signal was used 
to detect the gold particles, whereas the low-energy SEs provided the 
topographic information. This method requires that no heavy metals beside the 
gold particles are introduced during fixation and coating, in order to prevent 




3.3.6  Gold detection - accelerating voltage vs. penetration depth 
Generally, due to the presence of converted BSEs, the SE signal also carries 
the contrast details in the material as well. However, the accelerating voltage 
used may affect the depth of penetration of the incident beam. In our 
experiments, at higher accelerating voltage (10kV), a large amount of 
scattering events occurred in the colloidal gold. When the primary beam 
voltage was reduced (1–2 kV) the primary electrons were scattered or stopped 
before they reached the gold particles. This resulted in a surface image. Final 
images were captured at intermediate accelerating voltages (2-5kV). 
3.3.7  IG-TEM sample preparation protocol 
3.3.7.1 Fixation 
1. Enriched cell samples were immersed in 4% (w/v) formaldehyde in 1X 
PBS buffer, pH 7.4, at 4ºC for 4 hours.  
2. The fixative was removed by washing the sample thrice in 1X PBS 
buffer at 600g for 5 minutes. The sample was resuspended in 1X PBS 
and stored at 4ºC. 
3. At EM laboratory, the sample was post fixed in 1% Osmium tetroxide 
for 1 hour at room temperature (RT) and then spinned twice in de-
ionised water at 3000rpm for 10 minutes each. 
3.3.7.2 Dehydration and embedding 
1. The cellular pellets were then dehydrated in a series of increasing 





a. 50% ethanol :  10 minutes 
b.  70% ethanol :  10 minutes 
c. 95% ethanol :  10 minutes 
d. 100% ethanol :  30 minutes (2 changes) 
2. Next, the sample was infiltrated with LR-White resin (London Resin, 
Berkshire, United Kingdom) in the following manner: 
a. 1:1 LR White : 100% ethanol  30 minutes at RT 
b. pure LR White                     1 hour (2 changes) at RT 
c. pure LR White                      Overnight at RT (2 days) 
d. After 48 hours, pure LR White  1 hour (3 changes) 
3. After these changes, the cell pellets, embedded in pure LR White resin, 
were transferred in gelatin capsules and kept at 50ºC for another 48 
hours. 
3.3.7.3 Sectioning 
1. Block trimming: Specimen blocks, embedded in LR White resin, were 
trimmed using a single razor blade under the ULTRACUT-E 
dissecting microscope (Reichert-Jung). This was done to expose the 
sample and to form a trapezoidal cutting face. Figure 3.6 shows the 








2. Preparing knife: The knife used to cut thin sections was made from a 
special grade of plate glass. A trough, made from adhesive tape was 
attached to the knife to hold water onto which the sections would be 
cut (Figure 3.7).  
Figure 3.7: A glass knife prepared in the EM laboratory 
3. Ultramicrotomy: The trimmed specimen block was placed in the 
ultramicrotome and a semi thin section was cut first (Figure 3.8). This 
section was examined for presence of cells by staining with methylene 
blue.  The same procedure was repeated until sections containing cells 
were obtained. Then, the ultrathin slices (60-90 nm) containing cell 
sections were obtained on the same set up. Many of the slices were 
wrinkled in the cutting process. So, a heated probe was placed close to 
the floating sections until the wrinkles were removed. The slices were 
then mounted on a copper grid (250 meshes). The grids were stored in 





Figure 3.8: Ultra-microtome set up. 
 
3.3.7.4 Immunostaining procedure 
The grids with ultra-thin sections were transferred in the EM IGL automated 
immunostaining machine (Leica). Following steps were achieved in the 
machine in an automated manner. All incubations were carried at room 
temperature: 
1. Blocking with 1% BSA in PBS for 30 minutes. 
2. Wash with 1X PBS for 5 minutes (2 changes). 
3. Incubation with 50μl of anti-STEVOR antibody (1:25) for 60 minutes. 
4. Wash with 1X PBS for 5 minutes (2 changes). 
5. Incubation with 50μl of Au nanoparticles (10nm) conjugated goat anti-
rabbit secondary antibodies (Ted Pella, Inc.) for 60 minutes. 
6. Wash with 1X PBS for 5 minutes (2 changes). 




8. Wash with 1X PBS for 5 minutes (2 changes). 
3.3.7.5 Electron microscopy contrast staining 
- The grids were incubated with a drop of aqueous lead citrate solution for 8 
mins, and then washed twice with distilled water. 
-The ultra thin sections on grids were now ready to be examined on the TEM 
set up. 
3.3.8  TEM imaging set up 
Copper grids with ultra-thin sections were mounted on the specimen holder 
rod and inserted into the JEM1010 TEM column (JEOL) (Figure 3.9). The 
real-time set up is shown in figure 3.9. Samples were targeted with electron 
beam at primary acceleration voltage of 100kV. Images were taken with a 
high resolution ES500W camera (Erlangshen) at magnifications of 15000-
40,000. 






3.4  Results and analysis 
3.4.1  STEVOR clusters on iRBC surface - force mapping experiments 
Low resolution scans of iRBCs had revealed multiple large force rupture 
events in a substantial fraction of retraction force curves. As described earlier 
(2.4), probe-cell interactions were quantified in terms of force histograms and 
adhesion maps. The histograms provided us the quantitative information about 
the adhesive interactions whereas the colour scaled adhesion maps showed a 
complete spatial distribution of adhesion events on cell surfaces. A typical 
adhesion map generated from iRBC-functionalized tip interaction has been 
shown in figure 3.10.  
Figure 3.10: Adhesion map of a 4μm X 4 μm region on an iRBC surface    
(~150nm spatial resolution). Multiple boxed regions and other bright coloured 





As outlined in the map, multiple bright and moderate coloured patches were 
observed, indicating the occurrence of large force de-adhesion events in close 
proximity to each other on the cell surface. Retraction traces from force curves 
associated with these spatial points, revealed multiple bond rupture events of 
varying strengths. These dual probing experiments had been carried out at a 
spatial resolution of 64 X 64 pixels and the scan area for these cells was varied 
from 6-10μm. Thus, the force curves were typically recorded at incremental 
steps of 93-156nm in each direction.  
To further investigate these large force adhesion events and to get detailed 
insights about whether these proteins formed clusters on the cell surface, force 
scans of 1μm X 1μm regions were performed at 128 X 128 pixels and at 10 
times lower pulling speeds. Using this modified set of parameters, a spatial 
resolution of around 8nm could be obtained. Lower pulling speeds allowed the 
monitoring of bond rupture events at more precise magnitudes and time scales. 
Figure 3.11 shows an adhesion map obtained from one high resolution 
scanning experiment.  
A total of 15 unit area regions (5 each from 5A, A4 (tr-I) and A4 (tr-II)) from 
suspected high adhesion regions in full scans of mature schizont iRBCs were 
examined and around 2X105 curves were collected. Figure 3.12 shows some 





















Figure 3.11: Adhesion force map of a 1μm X 1μm zoom-in region on an iRBC 
surface. These scans were performed at 128 pixels X 128 pixels with a spatial 
resolution of ~8nm. Multiple number of bright spots with detachment forces as 





















Figure 3.12: some examples of retrace force curves associated with a (1μm X 
1μm) adhesion map represented in figure 3.11, multiple bond rupture events - 
both sequential and simultaneous, could be clearly observed in substantial 





Approximately 57% of these force curves were associated with multiple bond 
rupture events during the retraction phase. This indicated the presence of 
multiple STEVOR molecules in many nanoscale neighbourhoods of 8nm X 
8nm on the cell surface. All rupture force events in each retraction force curve 
were counted. Thus, the approximate number of STEVOR molecules was 
estimated in each neighbourhood. Figure 3.13 shows the size distribution of 
these protein clusters. Around 92.5% of the selected force curves were 
indicative of two or more STEVOR molecules being present in the 










Figure 3.13: Size distribution of STEVOR clusters on iRBC surface. 
3.4.2  Surface clustering of STEVOR - IG SEM 
SEM imaging of gold labelled late stage iRBCs, revealed interesting 
morphological images of cells. Along with other topological features in the 
normal SEM image, bright 10nm gold nanoparticles could be observed in back 




sizes on the cell surface. To ensure the specific binding of gold nanoparticles 
conjugated secondary antibodies to anti-STEVOR antibody molecules, 
negative controls were carried out by incubating the iRBCs directly with these 
conjugated secondary antibodies. Other control experiments including staining 
of A4 parasites and uRBCs were also carried out. As clear from the back 
scatter images, all these controls lacked any bright spot of gold nanoparticles 
in any part of the cell showing the absence of any non-specific binding (Figure 
3.15). 
 
Figure 3.14: Normal and back-scatter SEM images of a late stage iRBC. 
Normal SEM image shows the surface topology of the cell and the backscatter 
image shows the bright 10nm gold nanoparticles clusters conjugated to surface 
exposed STEVOR protein molecules. Scale bar, 2μm. 
 
Figure 3.15: Normal and back scatter SEM images of iRBCs in different 
conditions. Lack of bright spots in back scatter images of column 1, 3 and 4 





3.4.3  STEVOR localization in proximity to knobs on                            
iRBC surface - IG TEM 
TEM imaging of ultra thin sections of immunogold stained late stage iRBCs, 
provided new spatial insights into the membrane associated localization of 
STEVOR molecules. 5A and A4 (tr) clones were mainly used for this part of 
the study. Around 100+ iRBCs were imaged and analysis was performed. 
Qualitatively, TEM images of these cells showed that STEVORs were 
localized as clusters of varying sizes, and were mostly located in the close 
vicinity to surface knobs (Figure 3.16).  
Figure 3.16: TEM images of ultra-thin slices (~90nm) of different late stage 
iRBCs. Gold nanoparticles can be visualized in different parts of iRBCs, 
including MCs, membrane, iRBC surface, etc. Localizations of STEVOR 
molecules in vicinity to knobs should be noted. White arrows: 10nm Au 
particles; black arrows: knobs. Longer black scale bar, 2μm; shorter black bar, 
100nm; white bar, 50nm. 
 
The exact size distribution of STEVORs and extent of their localization in 
"knob proximity" were obtained by the quantitative analysis of TEM image 
sets. Figure 3.17 shows the size distribution of oligomers formed by STEVOR 
























Figure 3.17: Size histogram of Au nanoparticles clusters in TEM images. 
Error bars: SEM. 
 
Statistical quantification of TEM images suggested that of all the gold 
nanoparticles conjugated to the iRBC membrane, 73.48% were localized 













3.5  Discussion 
The distribution of STEVOR as molecular clusters on the iRBC surface and 
their localization in close neighbourhoods of knobs may provide additional 
survival advantages to the parasite during very late asexual stage of life cycle. 
Reinforcement of cytoadherence may be one such advantage. In previous 
studies, special knobby structures on iRBCs have been shown as the adhesion 
contact points between iRBCs and endothelial cells [71]. Thus far, PfEMP1 
clusters displayed on these knobs have been characterized as the single major 
group of cytoadherence mediating ligands [58, 64, 69]. It has also been shown 
that at very late asexual stages, the cytoskeleton of the iRBC degrades 
significantly in terms of protein network integrity and mechanical stability 
[203]. This progressive weakening of the iRBC cytoskeleton can directly 
affect the binding strength of the intercellular bonds formed at the knobs. This 
could make it more difficult for the parasite to anchor the sequestered iRBC 
under the same shear flow environment while it prepares to rupture. Based on 
our immuno-labeling experiments, a significant fraction of surface exposed 
STEVOR localizes in close proximity to these knobs and has been found to 
oligomerize in clusters of different sizes. These STEVOR molecules, in close 
proximity with knobs, may be able to provide extra support and stability by 









Functional role of surface exposed 
STEVOR antigens in rosetting interactions 
 
4.1  Preview 
This chapter presents the investigation into the functional involvement of 
variant STEVOR molecules in rosetting interactions between late stage iRBCs 
and uRBCs.  
First, we will describe two major biophysical techniques that will be employed 
in this part of the project - dual micropipette based force assay and 
microfluidics based flow rosetting assay. 
Then, we will describe various comparative assays that will be established 
with different clones and performed in two types of conditions - static and 
fluidic. We will also mention various control experiments that will be 
performed alongside in each of these conditions. 
Finally, we will proceed to present the results obtained from these assays and 
discuss in quantitative details the findings and their physiological significance 






4.2  Introduction 
4.2.1  Rosetting 
The phenomenon of rosetting in malaria is defined as the spontaneous binding 
of an iRBC with 2 or more uRBCs (Figure 4.1) [163]. Rosetting in P. 
falciparum malaria has been described as an important functional phenotype. 
As described in chapter 1, it has been associated with disease severity, parasite 








So far, PfEMP1s have been proposed to be the main mediators for 
sequestration and rosetting. Detailed studies have provided interesting insights 
into the mechanisms, role of different domains of these proteins in rosetting 
interactions as well as the receptors on erythrocytes which they bind with 
[168, 170, 171]. However, the fact that this protein family is unique to P. 
falciparum and that other Plasmodium species also do form rosettes [175, 
176], gives us clue about some PfEMP1-independent mechanisms being 
involved in these interactions. This possibility is further enforced by the 





observation that each iRBC expresses only a single member of PfEMP1, 
which again is linked to a specific adhesion phenotype [168, 169, 177, 178]. 
So, it may be possible that some other variant proteins can also mediate the 
rosetting phenomenon. One of the recent studies [179] has implicated 
STEVOR to be involved in rosetting interactions, by showing a positive 
correlation between the STEVOR expression level and rosetting ability of 
parasite clones. 
 Here, using quantitative biophysical assays - dual pipette aspiration based 
force assays and microfluidics based in flow rosetting assays, the ability of 
STEVOR proteins to mediate the formation of stable rosettes in static and 
dynamic conditions will be investigated. 
4.3  Experimental techniques 
4.3.1  Micropipette aspiration 
Micropipette aspiration is a simple but powerful biomechanical technique to 
manipulate cells, measure their mechanical properties and to quantify the 
adhesive interactions between various types of binding cells [180]. The basic 
schematic of the technique is shown in Figure 4.2. In the most basic form, i.e., 
single pipette aspiration method, a small diameter glass pipette is brought into 
contact with a cell. A known suction pressure is then applied within the 
pipette, causing an aspiration of the cell into the pipette. By measuring the 
length of aspiration, we can measure several important cell mechanical 
properties and related parameter (Figure 4.2(A)). Another pipette of suitable 
diameter can be put in from the other side and manipulated in a similar manner 




















4.3.2  Microfluidics 
Microfluidics is one of the very popular in vitro techniques to recreate and 
simulate "close to physiological conditions" environment [181]. It has been 
widely used in numerous studies involving cell adhesions, cell-matrix 
interactions, cell migrations and many other biological scenarios [181, 182]. In 




∆P ← Dp  
∆P: Negative aspiration pressure 
  ∆Lp: Aspirated length 








the shear stress dependent behavior of iRBCs and mimicks the environment in 
blood vessels [183-186]. This technique enables us to study the different types 
of interactions between cells under dynamic conditions. 
4.4  Experimental methods and assays 
4.4.1 Parasite cultures and enrichment 
5A, A4(tr-I) and A4(tr-II) parasites were cultured in vitro in human RBCs 
suspended in 1 X 1640 RPMI (Invitrogen) supplemented with Albumax I 
(Invitrogen), 2 mM L-glutamine, 50mg/ml hypoxanthine and 25mg/ml 
gentamycin at 2.5% hematocrit and incubated in an atmosphere of 3%O2, 
5%CO2 and 92%N2.  
4.4.1.1  Cell culture synchronization 
When majority of parasites were in the ring stage, synchronization by using 
5% sorbitol was conducted twice at 6-8 hour intervals in order to obtain 
trophozoite stage iRBCs in 12 hours and schizont stage iRBCs in 24 hours 
after synchronization. Parasitemia was assessed by microscopic inspection of  
Giemsa stained smears. 
4.4.1.2  Enrichment of late stage iRBCs 
Late stage infected cells from culture were enriched by Magnetic Assisted Cell 
Sorting (Miltenyi) setup in a similar manner as described in earlier chapters. 
The cell culture was centrifuged at 2200rpm for 5 minutes to get the cells as a 
condensed pellet. The pellet was then resuspended in 5 ml of MCM. After 
rinsing the LD column, the resuspended cell culture suspension was filled into 




at least five times. Next, the column was rinsed to isolate late stage iRBCs 
Sorted cells were centrifuged and resuspended in 3ml MCM.  
4.4.2  Rosetting selection 
Parasite cultures were repeatedly enriched for rosetting positive parasites by 
gelatin sedimentation approach as described earlier [187, 188] and the 
rosetting frequency (RF) - fraction of iRBCs involved in formation of stable 
rosettes, was quantified. 0.5% (w/v) gelatin solution was prepared by first 
dissolving 1 gram of animal grade gelatin (Sigma-Aldrich)) in 100ml of 1X 
PBS and later adding equal volume of RPMI. Final solution was sterilized by 
passing it through 0.2μm filter in BSC hood. The prepared gelatin solution 
could be stored for few weeks at 4ºC. Late stage trophozoite- and schizont-
stage iRBCs were resuspended at a 10% hematocrit in 37°C pre-warmed 0.5% 
(w/v) gelatin and allowed to sediment by standing for 1h at 37°C in a water 
bath. Non-rosetting iRBCs formed a clear upper layer whereas rosetting 
iRBCs settled down with uRBCs. Both rosetting and non rosetting-iRBCs 
were carefully separated, washed twice with RPMI, and then returned to 
standard culture conditions with fresh RBCs and complete RPMI. The 
rosetting selection was repeated once a week until a phenotype of at least 50% 
rosette frequency (RF) was obtained. For assessment of RF, parasite nuclei 
were stained with ethidium bromide (25 μg/ml) and 5-10 μl of suspension was 
mixed with mounting medium, placed on a microscope slide, covered with a 
cover slip and viewed with a 100Χ objective using an Olympus X71 
fluorescence microscope with both UV and bright field light to allow 




4.4.3  Static rosetting assays 
All rosetting assays were performed with late stage trophozoite and schizont 
stage iRBCs and quantified by rosetting frequency (RF). For the assay, cells 
from 10ml rosetting +ve culture were centrifuged to get the pellet. The pellet 
was resuspended in 3ml MCM and magnetically sorted to get enriched 
fraction of rosetting +ve late stage iRBCs. 20μl of purified late stage iRBCs 
(enriched by magnetic selection) were incubated with 200μl fresh RBCs and 
the pellets were resuspended in rosette binding medium (RPMI+20%FBS) and 
final volume was made to 1ml. The cells were allowed to interact with each 
other by incubating the suspension under rotating conditions for 60 minutes at 
37ºC. After incubation, 100μl of the suspension was mounted on a 35mm 
diameter glass bottom petri dish and visualized with a 100Χ oil immersion 
objective using an Olympus X71 fluorescence microscope. 
4.4.4  Antibody mediated inhibition in static and force assays 
To test if blocking of surface exposed STEVOR proteins with STEVOR 
antibody molecules would have any effect on rosette forming ability of iRBCs, 
magnetically purified iRBCs were incubated with anti-S1 serum for 1 h at 37 
ºC. Following 1 h of incubation, unbound antiserum was washed with RPMI, 
and pre-treated iRBCs were mixed with fresh RBCs to form rosettes under 
rotation for 1 h at 37ºC as previously described.  
4.4.5  Micropipette preparation 
Borosilicate glass tubes with outer diameter of 1mm, inner diameter of 0.5mm, 




were mounted onto a micropipette puller (Sutter Instruments). The pulling 
speed, heating time, melting power and other involved parameters were pre-set 
to optimal conditions in micropipette puller. The tube was heated in the central 
region and pulled from both sides simultaneously causing progressive 
shrinking of cross section from edge towards centre part which eventually led 
to breakage of the tube into two pipettes with considerably smaller cross 
sections at their ends. However, as these ends were obtained by melting and 
pulling processes, the final cross sections could not be controlled precisely. 
Hence, the raw pipettes were mounted onto the micro forge (Narashige) to cut 
and polish the pipette to get appropriate inner diameter. 
4.4.6  Cell chamber preparation 
The cell chamber was prepared by attaching two different sized cover slips 
with parafilm as the intermediate glue pillar set. 2inch X 2inch parafilm sheet 
was repeatedly cut into smaller pieces which stacked on top of each other until 
12 layers were formed. The resulting stack was cut into smaller pillar blocks. 
Each block pair was placed on a 25mm X 60mm cover slip on opposite longer 
sides in middle section of the edge. Another 22mm X 22mm cover slip was 
gently placed on top of the parafilm blocks and entire assembly was heated on 
a heating plate at 80ºC until the two parafilm blocks partially melted and glued 
the two cover slips together to form the cell chamber (Figure 4.3). 
 
 





4.4.7  Dual pipette force assays 
To measure the binding forces in rosettes, the micromanipulation technique 
based on micropipette aspiration was used [189, 190]. Attached uRBCs were 
pulled out from rosettes in an individual manner on the stage of an inverted 
epifluorescence IX71 microscope (Olympus) equipped with a high resolution 
QColor5 Color CCD Digital FireWire Camera (Olympus) and detachment 
forces were measured. Hollow borosilicate glass tubes (Sutter), were pulled on 
a S2000 puller (Sutter Instruments), cut and fire polished on a micro forge 
(Narishige) as described earlier, to get micropipettes of internal diameter (  ) 
in 2-3μm range. In each experiment, iRBCs were manipulated with two 
micropipettes, each supported by one micromanipulator (Eppendorf) making it 
possible to direct the movement of pipettes during the experiment. The 
Eppendorf micromanipulator is a motorized manipulator, which can be used to 
control the position and movement of the micropipette in steps down to a few 
microns. The left micropipette was further connected to an integrated 
pneumatic system of automated syringe pump, manual syringe, two burette 
columns and a pressure sensor (Validyne) (Figure 4.4).  
 
Figure 4.4: Image of the micropipette aspiration set up to measure the binding 




The syringe pump and the manual syringe were used to inject water into fluid 
burettes and control the liquid height during the experiments. Thus, a negative 
or positive pressure could be applied the micropipette tip end. The P55 
compact differential pressure transducer (Validyne) was used to convert the 
static pressure difference into electric voltage signal which was read using a 
digital voltmeter. This arrangement allowed us to precisely measure the 
aspiration pressure while pulling away a single uRBC from rosette. Right 
micropipette was just connected to a reservoir PHD 2000 syringe pump 
(Harvard Apparatus) which could be manually operated to create enough 
negative pressure to hold a rosette stationary in the micropipette still exposing 
attached uRBCs in solution. Aspiration of a particular uRBC           
    where N is the size of the rosette, was monitored continuously during the 
separation process. Suction pressure values were recorded for last two frames, 
when uRBC      being pulled just detached from the rosette. Average of these 
two pressures,         was put as the average suction pressure required to 
detach      from the cluster. The individual detachment force to separate 
uRBC      from the cluster was calculated as 
                     
                                  (4.1) 
The final average binding strength of the rosette was calculated by averaging 
out individual binding force values as  
                                                
 
 
                   (4.2)  





4.4.8  Flow rosetting assay - conceptualization of the protocol 
 The complex interplay between various phenotypes of malaria parasite during 
disease pathogenesis makes it really difficult to study the individual 
contribution each of these phenotypes provides for the sustenance of the 
infection inside the body. For example, during P. falciparum infection, iRBCs 
not only bind to various receptors on endothelial walls of different tissues 
(cytoadherence) but can also adhere with other uRBCs flowing in blood 
stream (rosetting). The ability of the parasite to exhibit multiple phenotypes at 
the same time can be attributed to two factors - the large number of different 
ligands exported by the parasite and the ability of many surface antigens to 
bind to a variety of receptors on different types of cells like endothelial cells, 
uRBCs, and platelets. For example, PfEMP1 variants, members of the well 
characterized var gene family, have already been shown to be functionally 
involved in cytoadherence as well as rosetting phenomena [168-170]. So, in 
order to investigate the contribution of one class of parasite derived surface 
antigens in a particular functional phenotype, a double standardized in vitro 
functional assay has to be established. In this study, we were interested in 
studying the role of STEVOR proteins in rosetting phenomenon. So, our target 
was to first simulate the in vivo like environment to observe the in-flow 
rosetting interactions and then isolate the role of STEVOR proteins in this 
phenomenon. This formed the basis of our established microfluidic assay. 
So far, there has not been any evidence about ring stage iRBCs interacting 
with uRBCs to form rosettes, hence, we postulated that rosetting phenotype 




stages are believed to be sequestered in deep vasculature [164, 165], our first 
target was to make late stage iRBCs adhere to the base of the microfluidic 
channel. This could be attempted in one of the following ways: 
1. Coating the channel with an endothelial receptor (CD36/ICAM-1) 
In this approach, the microfluidic channel would be coated with one of the 
well established endothelial receptors - CD36 or ICAM-1. The strain of 
interest could be first selected for the receptor and then flowed into the 
channel. The preferential binding affinity between parasite derived ligands and 
endothelial receptor would induce a large subset of flowing iRBCs population 
to adhere to the bottom of the channel. Rosetting environment could then be 
attempted by flowing in isolated uRBCs and observing the interactions 
between flowing uRBCs and adhered iRBCs. Correlative evidences based on 
expression of STEVOR proteins in a given strain and its rosetting ability in 
flow would provide clue on functional involvement of STEVORs in this 
phenomenon. However, there were some issues which would drastically affect 
the outcome of these experiments. As has already been shown in literatures, 
due to lack of immune pressure over a long period of time, the surface 
expression of variant antigens on laboratory strains is normally quite low [191, 
192]. Hence, in order to observe any kind of functional phenotype, these 
strains need to be first selected for the receptor of interest for several rounds. 
In this approach, to make the iRBCs adhere in the flow channel, the rosetting 
selected fractions of clones 5A, A4, A4 (tr-I) and A4 (tr-II) were selected for 




the increased cytoadherence levels of late stage iRBCs in CD36 coated flow 
channels but drastically reduced the rosetting efficiency of these cells.  
2. Periodic selection of strains for rosetting and cytoadherence 
In order to achieve the rosetting and cytoadherence interactions in the flow 
channel at the same time, another possible strategy that was attempted to 
develop was periodic selection of clones for rosetting and cytoadherence 
phenotypes. As discussed earlier, laboratory strains require regular selection in 
order to express a particular adhesion phenotype [191]. So, the strains were 
selected for rosetting and CD36 alternatively for several weeks using the 
protocols similar to as described in [193]. However, this turned out to be quite 
time consuming procedure. Also, sufficient level of binding efficiency could 
not be achieved with any of the phenotypes as selection for one adhesion 
phenotype might have down regulated the expression level of ligands for other 
phenotype in laboratory conditions.  
3. Coating the microchannel surface with glycophorin-C 
One of the recent studies has shown that STEVOR binds to glycophorin-C 
receptors on uRBCs [179]. So, one possible approach to make late stage 
iRBCs adhere to channel bottom could be to coat the surface with excess of 
glycophorin-C and then proceed with rest of the experiment. However, 
purified glycophorin C could not be arranged easily. Also, the previous study 
was performed in static conditions and the binding strength of the ligand-
receptor pair was not quantitatively clear. Hence, even if the purified protein 




surface could not be ensured in a convincing manner and that might affect the 
subsequent steps in the assay.  
4. Coating the channel with anti-STEVOR serum 
Alternatively, the strains could be directly selected for rosetting phenotype as 
described earlier and the microchannel could be coated with excess of anti-
STEVOR serum. In general, protein-antibody bonds are expected to be quite 
strong. Our AFM force mapping experiments also revealed the similar 
findings. So, strong protein-antibody affinity would lead to the adherence of 
flowing iRBCs without compromising the rosetting behaviour of cells. 
Subsequent flowing of uRBCs would further simulate the rosetting 
interactions environment in microfluidics assay. 
Based on results from our trial experiments with various possible approaches, 
coating of microfluidic channel with anti-STEVOR serum yielded highest 
adhesion efficiency of late stage iRBCs to the channel bottom while 
maintaining the rosetting phenotype of cells under appropriate flow 
conditions. Hence, this approach was finalized as the starting step for in-flow 
rosetting assay. 
 
4.4.9  Microfluidic channel preparation 
Microchannels were made using a SU-8 photoresist mould and a polymer, 
polydimethylsiloxane (PDMS). The 2D design of the channel was first drawn 
using Autodesk AutoCAD® to print a photo mask. Next, the SU-8 mould was 




4.4.9.1  Photolithography for mold fabrication 
Photolithography, also termed optical lithography, is a process that utilizes 
light to transfer a pattern from the photo mask onto a light-sensitive 
photoresist substrate. The photo mask can be polyester film mask or fused 
quartz with patterns on a layer of chrome. The material commonly used as 
photoresist for microfluidic molds is SU-8. It is an epoxy-based negative 
photoresist and can be used to pattern high aspect ratio of more than 20 [195]. 
Upon exposure to UV, the long molecular chains of SU-8 crosslink and 
solidify the material. The area blocked by the photo mask is subsequently 
washed off in the developer. Consequently, a negative pattern is transferred 
onto the substrate for the fabrication of the microfluidic mold. 
4.4.9.2   Microchannel from mold 
Microchannels were fabricated with Polydimetholysiloxane (PDMS) polymer 
using the protocol as described in [201]. PDMS is a widely used polymer for 
the manufacturing of microfluidic chips. The pre-polymer base was mixed 
with the cross-linking agent (SYLGARD) to get the cross-linked hydrophobic 
elastomer PDMS. The cross linked PDMS is transparent, deformable, bio-
compatible, gas permeable and inexpensive compared to previously used 
materials such as silicon.  
The details of the steps involved in the fabrication of the channel are as below: 
A. Master mold fixation. The mold fabricated after photolithography was 




B. Silane deposition. A thin layer of Trichloro (1H, 1H, 2H, 2H-
perfluorooctyl) silane vapour generated in vacuum was deposited on the 
master mold. The application of silane was to ensure easy detachment of 
the PDMS from the mold after curing. 
C. PDMS pouring and curing. PDMS mixed with 10% cross-linking agent 
was poured onto the silane coated master mold and degassed in vacuum. 
Degassing is essential to avoid bubbles within the mixture and to ensure 
the transparency of the PDMS after curing. Thereafter, it was placed in the 
80°C oven for curing. During this process, the cross-linking agent cross-
links PDMS and hardens it.  
D. PDMS channel peeling. The hardened PDMS was first cooled to room 
temperature and then peeled. Two holes were punched at the ends of the 
channel to form the inlet and outlet ports. 
E. PDMS bonding. Plasma oxidation of PDMS produces silanol terminations 
(SiOH) that is able to covalently bond to an oxidized glass surface by the 
creation of a Si-O-Si bond. After plasma treating the peeled PDMS and 
glass slide, the two surfaces were bonded together. The bonded channel 
was then ready to use after further baking in the 80°C oven for 2 hours 
[201] 
4.4.10  Flow rosetting assay - cell sample preparation 
For the assay, cells from 10ml rosetting +ve culture were centrifuged to get 
the pellet. The pellet was resuspended in 3ml MCM and magnetically sorted to 




resuspended in rosette binding medium (RPMI+20%FBS) to a final volume of 
1mL and incubated at 37ºC to be used for the flow experiments. 
4.4.11  Functionalization of channel bottom surface 
Before each experiment, the channel was pre-cleaned with 70% ethanol, 
followed by washing with distilled water. The cleaned channel was placed a 
35mm diameter petri dish and then filled with 20 µl of anti STEVOR serum 
(diluted 1:100). The empty space in petri dish was filled with pieces of wet 
tissue papers, sealed firmly with parafilm and incubated overnight at 4 °C. 
Next day, the channel was taken out and washed gently with 1X PBS 
(Invitrogen) to remove excess of the antibody.  
4.4.12  Flow set up 
The microchannel, already functionalized with anti-STEVOR antibodies on its 
bottom surface, was cleaned properly with freshly prepared 1X PBS. The 
cleaned channel was filled with 4% BSA (Millenyi Biotec) and incubated for 
around 30 minutes to block possible non-specific binding of cells to the 
channel surface during flow assays. After incubation, the channel was again 
washed thoroughly with 1X PBS and mounted on the stage of Olympus X 71 
inverted microscopes. The output port of the channel was connected to the 
flexible tube filled with water, the other end of which could be conveniently 
placed at a suitable height difference with respect to microscope stage.  
This arrangement allowed precise and smooth control over the flow shear 




of inlet port to keep the entire channel filled and thus avoid entry of any 
bubbles. 
Table 4.1: Various biophysical parameters in flow assays 
Parameter Value/range 
Dimensions of channel 50μm (height) X 500μm (width) 
Wall shear stress 0.05-0.2Pa 
Flow type Pressure driven  
(pressure gradient induced by  
the static water column set up) 
Flow time for iRBCs 30 minutes 
Incubation 30 minutes 
Flow time for uRBCs 90 minutes 
 
4.4.13  Flow rosetting assay experiments 
For each assay, the enriched R+ iRBCs, suspended in rosette binding medium, 
were flowed in the microchannel, prepared as above described, at a very low 
shear stress (~0.05Pa). During flow, strong binding interactions between 
STEVOR proteins on surfaces of flowing iRBCs and anti-STEVOR antibody 
molecules on the bottom surface of microchannel facilitated the adhesion of 
these cells resulting in a subset of flowing iRBC population getting adhered to 
the channel surface (Figure 4.5). After 15 minutes, the channel was placed in 
an incubator at 37ºC for another 15 minutes to allow stable binding of proteins 
and antibody molecules so that cells could remain well adhered during second 
phase of flow experiment. After gently washing the channel with rosette 
binding medium buffer to remove unbound iRBCs, uRBCs suspended in 
rosette binding medium were flowed in at shear stress of ~0.1Pa. Different 
sections of the channel were imaged at regular intervals on the Olympus IX71 





Figure 4.5: Schematic of in-flow rosetting assay. IRBCs are flowed in an anti-
S1 coated microchannel. After iRBCs are adhered, uRBCs are flowed in. 
4.5  Results 
4.5.1  Static rosetting assays 
First, static rosetting assays were established with enriched rosetting-positive 
(R+) cultures of 5A, A4, A4(tr-I) and A4(tr-II) clones and rosetting efficiency 
of parasites was quantified in terms of rosetting frequency - fraction of iRBCs 
involved in formation of stable rosettes (Figure 4.6). The sizes of the rosettes 
formed in these assays were also quantified and the statistical distribution is 
shown in figure 4.7. Rosetting frequency of 70.6±4.5% was observed with 5A 
parasites in static assays and stable rosettes of various sizes, with up to 10 




down to 25.8±3.96% when the enriched 5A R+ iRBC populations were pre-
incubated with anti-S1 serum for about 60 minutes at 37ºC. On the other hand, 
only 3.8±1.5% parasites formed stable rosettes in A4 clone, with most of them 
having two uRBCs attached to an iRBC, and negligible change was observed 
in rosetting population fraction upon an hour long pre-incubation with anti-S1 
serum at 37ºC. Both A4(tr) clones, however, showed remarkably higher 
rosetting frequency - 55.8±4.1% for A4(tr-I) and 60.8±6.7% for A4(tr-II), as 
compared to A4 parasite and pre-incubations with anti-S1 serum under 
identical conditions significantly prevented rosette formation (17.8±3.11% for 


















Figure 4.6: Rosetting frequency comparison between 5A, A4, A4 (tr-I) & A4 
(tr-II) clones in static conditions with different treatment procedures. Each bar 



























Figure 4.7: Size distribution of rosettes formed by 5A, A4, A4 (tr-I) & A4 (tr-
II) parasites in static incubation conditions. 
 
This demonstrates the direct role of STEVOR proteins in rosetting 
interactions. Pre-incubation of 5A and A4 (tr) parasites with rabbit Isotype 
serum had negligible effect on the rosetting efficiency and size distribution of 
rosettes formed by these parasites. 
4.5.2  Calibration of the micropipette set up 
The reading from the pressure transducer, which was read in voltage, 
corresponded to the hydrostatic pressure of water column 1 relative to water 
column 2, as shown in figure 4.4. Thus, it was very important to find the 
absolute pressure as well as the conversion factor between pressure and output 
voltage. Once the absolute pressure had been obtained, the force to detach the 




The zero pressure was obtained by carefully adjusting the height of water 
column 1, while keeping water column height constant. To determine the zero 
pressure, the left micropipette was brought right next to an uRBC. When the 
cell was neither pushed away nor aspirated into the pipette, the voltage reading 
in the digital voltmeter was noted down as zero pressure or  
 . 
Figure 4.8: Calibration graph for digital voltmeter voltage reading and burette 
fluid level. The volume marker directly corresponds to the amount of negative 
pressure created to aspire the uRBC in micropipette. 
The relationship between pressure and output voltage was calibrated by 
varying the water level in column 1 between different volume markers on the 
25mL Falcon burette. The distance between each volume maker was pre-
measured to be 2cm. Thus, by assuming the absolute pressure when water 
level reached marker 3mL to be   
  and 4mL to be   
 , the pressure difference 
between   
  and   
  was calculated from the difference in water level height 
∆h and tap water density ρ,        , where g is the standard acceleration 
due to gravity defined to 9.807m/s
2




was recorded as water column reached marker 3, 4, 5, 6 and 7, it was found to 
be linearly dependent. 
Table 4.2 shows a typical experimental measurement of the voltage 
corresponding to each water column, and the slope L of the linear relationship 
could be obtained by curve fitting. 
Table 4.2: Voltage vs. voltmeter reading calibration data used to convert the 
voltage readings into corresponding pressure difference values 







The change in the voltmeter reading with 1mL change in volume marker on 
the burette (or 2cm change in height) was found to be 0.7288Volts. 
The pressure difference corresponding to 0.7288V change in voltmeter reading 
was calculated as 
                             
      
  
 
     
  
                  (4.3) 
Thus, if we know the corresponding voltage reading 0Pa or  
 , the pressure at 
any water level height can be calculated as, 
                                                  
        
        
             (4.4) 
Here    is the pressure of water column,    is the corresponding voltmeter 




voltmeter reading at zero 0Pa, which was measured at the beginning of the 
experiment. Thus, the value    can be calculated as  
                                                  
             
 
   (4.5) 
4.5.3  Comparison of rosette binding strengths amongst different clones- 
dual pipette force assays  
To quantitatively investigate the contribution of STEVOR proteins in rosetting 
interactions and test the strength of formed rosettes, quantitative force assays 
were performed with 5A, A4 and A4(tr) clones wherein forces required to 
remove individual uRBCs from stable rosettes were computed using dual-
pipette aspiration technique. For each measurement, the rosette was first held 
stationary in suspension by aspirating from iRBC side in the bigger pipette and 
attached uRBCs were aspirated simultaneously in the smaller pipette on the 
other side by applying negative pressure gradient while recording the final 
voltage output for each cell detachment event from the rosette assembly 
(Figure 4.9).  
Figure 4.9: Microscopic images of a rosette during force assay experiment. 
Left image shows the initial stage when the aspiration of uRBC is set start, the 
right image shows the moment when the uRBC is just about to get detached 




As described earlier, the voltage readings were converted into corresponding 
absolute pressure values using the pressure-voltage calibration chart and 
processed to get detachment force values (Figure 4.8). Mean binding force 
was computed for each rosette as the average of individual detachment force 
values required to separate all uRBCs in that rosette. Figure 4.10 shows the 
distribution of mean binding force value per rosette for different clones. A 










However for A4 parasites, the yield was low in terms of rosette count, so only 
10 rosettes could be manipulated for force measurements. Strong binding 
forces (mean: 531.7±85.2pN) were observed between iRBC-uRBC pairs in 5A 
parasites which significantly reduced down to an average of 144.2±46pN, 
Figure 4.10: Comparison of mean binding strength of rosettes formed by 
clones - 5A, A4, A4(tr-I) & A4(tr-II) clones in normal and pre-blocked 
rosetting assays. Each data point shows the binding strength of one rosette. 
Upper and lower limits of boxes show the 25th and 75th percentile 
respectively and whiskers show the extreme values of each side of the box. 




when the cultures of iRBCs were pre-incubated with anti-S1 serum for 60 
minutes at 37ºC before the rosetting assays were established. As described 
earlier, very few stable rosettes were observed with A4 parasites and only 10 
of the rosettes could be analysed by force assay However, the average binding 
strength was found to be consistently low in all of these rosettes (mean: 
91.9±10.8pN) which was almost unaffected by pre-blocking with anti-S1 
serum. A4(tr-I) and A4(tr-II) clones with average detachment forces of 
425.7±77.3pN and 509.3±80.8pN, respectively showed a huge increase in 
binding strength as compared to A4 clone thus demonstrating the direct 
modulation of rosette strength by STEVOR proteins. Similar pre-incubation 
treatments of R+iRBCs with anti-S1 serum lowered the average binding 
strength to 175.3±32.4pN for A4 (tr-I) clone and to 126.9±39.9pN for A4 (tr-
II) clone. Rabbit isotype serum pre-incubation, had no observable effect on the 
strength of the formed rosettes. 
Using the experimental force values obtained from all these experiments, the 
contribution of STEVOR alone in rosette binding strength could be calculated 
as ~400pN (details in appendix). 
In order to investigate whether disrupted rosettes could be reformed under 
suitable contact conditions, the iRBCs from these rosettes were brought back 
into contact with other fresh uRBCs in suspension. The contact was 
maintained for various time intervals and cells were separated again by 
applying negative pressure from the uRBC side. Adhesion was initiated quite 
rapidly for all parasite clones and even for contact times of < 1min, cells were 




not stable and aspiration force values fluctuated every time. As the contact 
duration between the cell pairs was increased at regular intervals from 5 mins  
to 60 mins, the detachment forces increased rapidly with values stabilizing to 
the original detachment strength of the binding pair after 30-40 mins of 










Figure 4.11: Time dependent rosette binding forces in reformation assays. 
Data: mean ± SEM; 10 cell pairs for each time point. 
 
 
4.5.4  STEVOR mediated rosetting in flow 
To test whether STEVOR proteins were capable of mediating the formation of 
rosettes under flow conditions, microfluidics based rosetting-flow assays were 
established with rosetting selected 5A, A4 and A4 (tr-I&II) clones. Under 0.1-
0.2Pa shear flow conditions, rosettes of different sizes could be observed with 
R+5A and R+A4 (trI & trII) parasites whereas R+A4 parasites failed to form 








Figure 4.12: Microscopic images of in-flow assays for all four clones. First 
column shows the DAPI stain for first three clones and GFP STEVOR for last 
row (A4 (tr-II) clone); the second column shows the bright field images of 




Figure 4.13 shows the size distributions of stable rosettes formed by clones 







Figure 4.13: Size distribution of rosettes formed by clones - 5A, A4 (tr-I) & 
A4 (tr-II) in in-flow rosetting assays. 
The time dependent response of different clones as the uRBCs gathered 



















Figure 4.14: Plot showing the time dependent rosetting behaviour of 4 clones 






For 5A clone, 30±3.4% rosetting frequency was observed after around 50-60 
minutes from the time flow of uRBCs was initiated. Similar responses were 
obtained with A4 (tr-I) and A4 (tr-II) clones which exhibited around 33±4.7% 
and 39±4.2% peak rosetting frequency respectively after about an hour from 
the start of uRBCs flow. With A4 clone, around 4% rosetting frequency was 
observed after around 30-40 minutes from start time of uRBCs flow in the 
channel. However, these clusters were transient in nature and most of them 
disrupted with time.  
The relatively lower yield of rosettes observed in these flow assays, as 
compared to static assays, can be attributed to a number of factors. Firstly, in 
order to image the channel sections clearly, the concentration of fresh uRBCs 
in flow was kept lower. This significantly reduced the uRBCs/iRBCs ratio in 
the flow assay. The unidirectional flow in the assay also reduced the iRBC-
uRBC interaction time, leading to the lower binding probability between cells. 
Also, pre-adherence to channel bed decreased the exposed surface area and 
hence the available STEVOR content on iRBCs.  
Taken together, these assays showed the direct involvement of surface 
expressed STEVOR in mediating the formation of stable and robust rosettes 







4.6  Discussion 
In this part of the project, dual-pipette aspiration based force assays and 
microfluidics based rosetting assays were carried out in order to study the 
ability of STEVOR to mediate the formation of stable and robust rosettes 
under static and physiologically relevant flow conditions. Our results show 
that STEVOR can mediate the formation of strong and stable rosettes under 
static as well as physiologically relevant dynamic environment. 
Rosetting, an important adhesion phenotype of the disease, has been 
associated with complicated malaria in large majority of clinical cases [163-
166]. This phenomenon is believed to confer multiple advantages to the 
parasite. One hypothesis suggests that rosettes not only provide the maturing 
parasite an opportunity to shield itself from immune cells, but also allow the 
emerging merozoites to easily invade fresh target uRBCs [166]. However, this 
idea has been challenged by certain studies wherein no direct correlation 
between the rosetting phenotype and parasitemia was observed [197, 198]. 
Thus far, PfEMP1 has been implicated as the major ligand involved in 
mediating the cytoadherence and rosetting of iRBCs [170, 171, 199]. 
However, the expression of PfEMP1 like proteins and endothelial 
sequestration have been largely restricted to P. falciparum malaria and 
rosetting has been observed in all human malaria species as well as in simian 
and rodent malaria parasites [172-176]. Importantly, while no homologues of 
PfEMP1 have been found in species P.knowlesi and P. reichenowi, 
homologues of small variant antigens such as STEVOR and RIFIN are present 




during the disease, each iRBC expresses only a single member of PfEMP1 
family which is linked to a specific adhesion phenotype [168, 169, 177, 178]. 
Assuming PfEMP to be the only ligand mediating the adhesion of iRBCs, this 
exclusive nature of PfEMP1 mediated adhesion phenotypes would imply that 
at a given time, a single iRBC can either form a rosette or cytoadhere onto the 
endothelial cell wall. Instead, coexpression of rosetting and cytoadherence 
receptors on the same P. falciparum iRBC, as shown in some earlier studies 
[137] suggests that an individual iRBC can express multiple surface ligands 
simultaneously. This idea is further supported by recent studies, wherein the 
other variant antigen families of STEVOR and RIFIN have also been shown to 
be capable of mediating rosetting of P. falciparum malaria [102, 179] in 
PfEMP1 independent manner.  
Our results here provide direct visual-quantitative evidence into the role of 
STEVOR in mediating stable and robust rosetting interactions in static and 
flow conditions. We show, using dual pipette force assays and flow based 
rosetting assays, that these STEVOR mediated rosettes are also quite stable 
and robust in nature. This is evident from the strong binding forces exhibited 
by STEVOR mediated rosettes. Also, in reformation assays, we show that 
these rosettes, even once disrupted, can easily form back with binding forces 
reaching to original strength in around 30 minutes. In flow assays, formed 
rosettes, after getting detached from the bottom surface of the channel, could 
flow intact in flow at higher flow shear stress conditions. This reflects the 




An important quantitative aspect of our work is the demonstration of the fact 
that STEVOR can independently generate a binding force of 396.8±81.6pN in 
a rosette (details in Appendix). This value is comparable to the rosette binding 
strength of 440±130pN, observed in one of the earlier studies [185, 190]. In 
another work, average detachment forces of ~100pN were observed between 
iRBCs and cultured endothelial cells lines expressing CD36 and ICAM-1 
[190]. A more recent study quantifies the average adhesive forces between 
FCR3CSA late stage iRBCs and CSA expressing CHO cells to be in the range 
of 100-200pN [196]. These comparisons suggest that STEVOR mediated 
rosettes, with much stronger binding forces as compared to forces in 
endothelial sequestration, are quite stable and robust in nature.  
Therefore, the adhesive properties of rosetting and cytoadherence of the P. 
falciparum parasite may not be regulated by a single variant antigen group, but 
are probably the combined effect of different variant antigen families being 

















Conclusions & future work 
5.1  Conclusions 
STEVOR proteins have been identified as the members of the third largest 
variant antigen family exported by P. falciparum parasite. Being expressed in 
different stages of parasite life cycle, these proteins have been believed to be 
involved in important functional attributes associated with the disease 
pathology. Efforts are being made to understand, in more detail, the expression 
profiles and functional roles of this protein family. However, limited direct 
visual-quantitative evidences are available about the exact morphological and 
functional characterization of these proteins. Hence, this thesis focused on 
providing a comprehensive set of insights about the expression dynamics of 
STEVORs during asexual stages and their functional role in rosetting of 
iRBCs under static and dynamic conditions. 
We investigated STEVOR proteins on the surface of iRBCs using AFM force 
mapping. For force mapping, we immobilized anti-STEVOR antibody 
molecules on AFM cantilever tips and probed target iRBCs with these 
functionalized tips. With our experiments on iRBC populations from different 
clones, we were able to directly demonstrate the extracellular presence of 
these proteins on late stage iRBCs. Further analysis of cumulative force 
mapping data revealed that surface expression level of STEVOR increases 




late schizont stages. Based on the AFM experiments, we also concluded that 
the architecture of STEVOR molecule comprises of only one trans-membrane 
(TM) domain as opposed to earlier modeling based speculations which 
predicted STEVORs to be a part of 2-TM family.  
Next, we characterized the spatial distribution patterns of STEVOR on iRBC 
surface, in detail. Ultra-high resolution AFM force mapping on 1μm X 1μm 
regions of late stage iRBCs from three STEVOR +ve clones revealed that a 
significant fraction of STEVOR molecules formed oligomers of varying sizes 
on the surface of the iRBC. Immuno-gold SEM imaging of late stage iRBCs 
also showed different sized clusters of gold particles on the surface of iRBCs. 
This supported our findings from AFM force mapping experiments. In order to 
look at these molecules further closely, we performed immunogold TEM 
imaging of the ultra thin slices of late stage iRBCs. These EM experiments 
enlightened us with interesting insights about the localization patterns of 
STEVOR molecules. First, in consistency with previous studies, we found Au 
nanoparticles to be co-localized with Maurer's Clefts (MCs) below the iRBC 
membrane and also on the extracellular surface of the cell. We also observed a 
substantial fraction of the nanoparticles in close proximity to knobs on the 
iRBC membrane. This provided us the evidence about the localization of 
STEVOR in close neighborhoods around surface knobs. 
We also performed detailed experimental tests to study the functional role of 
STEVOR in formation of rosetting clusters. First, we established static 
rosetting assays with different clones and quantified rosetting frequency. All 




the control A4 clone. This proved the involvement of STEVOR in mediating 
rosetting interactions in static environment. Next, the force analysis of rosettes 
from all different clones provided quantitative evidence for the binding 
strength of STEVOR mediated rosettes. We observed strong binding forces, in 
the range of 400p-700N, between iRBC-uRBC pairs in rosettes formed by 
STEVOR +ve clones which are very much comparable with earlier values 
reported wherein the rosettes were believed to be mediated by PfEMP1. We 
also tested the reversible nature of these rosettes with time dependent 
reformation assays. Rosettes from all three STEVOR +ve clones exhibited 
strong rebinding behavior. These observations further supported the stable 
nature of these rosettes. Having established the specific role in static rosetting, 
we further tested STEVORs for their ability to mediate the formation of 
rosette clusters in physiological flow. All STEVOR +ve clones were able to 
form stable clusters of different sizes at various locations in flow channels. 
Based on these findings, we concluded that STEVORs can mediate the 
formation of rosettes under physiological flow conditions as well. 
Taken all together, this study established that as the parasite grows within the 
iRBC, a fraction of STEVOR family is progressively exported beyond MCs to 
the iRBC surface where it forms clusters of different sizes and preferntially 
localizes in close vicinity to the knobs. Also, surface exposed STEVORs can 
mediate the formation of stable and robust rosettes in static and physiological 
environment. Finally, our study highlights the physiologically relevant 





5.2  Future works 
This thesis has developed interesting visual-quantitative findings about export 
and functional role of STEVOR proteins in late asexual stages of P. 
falciparum malaria. In this study, we employed functional assays and different 
microscopy techniques to study and characterize the expression dynamics and 
functional aspects of this protein family. This work has thus provided a basic 
knowledge platform and a hierarchical analysis framework to study and 
analyze the biophysical aspects of the disease pathology. However, following 
important points can be addressed in order to further strengthen our 
understanding of these issues. 
Transport of STEVOR to iRBC surface - role of KAHRP 
As observed in our immunolabeling based TEM experiments, STEVOR 
preferentially localizes in proximity to knobs. It might be interesting to look at 
the role of KAHRP protein in the transport and localization of STEVOR to 
iRBC surface.  
Clustering mechanisms & interactions with host iRBC cytoskeleton proteins 
A detailed analysis of different domains of STEVOR may provide further 
insights into the clustering mechanisms of STEVOR molecules and their 
interactions with host cell cytoskeleton proteins. This could also establish the 






Role of STEVOR in cytoadherence at very late asexual stages 
As discussed in chapter 3, STEVOR may functionally get involved in multi-
tasking affairs at very late asexual stages. Clusters of STEVOR in close 
vicinity of surface knobs may provide extra anchoring support to fragile iRBC 
by binding to certain endothelial receptors. Hence, functional studies, 
exploring the possibility of binding interactions between STEVOR and 
endothelial receptors, may provide interesting experimental clue in this aspect. 
Role of STEVOR in antigenic variation 
 As discussed in chapter 2, STEVOR family on iRBC surface may participate 
in antigenic variation thus enhancing the immune evasion ability of the 
parasite and enabling it to safely complete the development cycle. However, 
lack of sufficient evidence thus far in support of this hypothesis, makes it an 
interesting avenue for future investigations.  
Potential therapeutic interventions in malaria pathology 
This work lays foundation for the new aspects to be discovered about 
STEVOR export to surface and its potential implications in the disease 
pathology. Detailed future studies may provide us with a single or a set of key 
molecules that might be critical into the signalling and transport mechanism of 
STEVOR onto the iRBC surface. This may further motivate researchers to put 
efforts in blocking or reversing the signalling and STEVOR transport process. 
Based on these interventions, we may be able to reduce, prevent or even 
reverse the complications of STEVOR mediated rosetting in P. falciparum 




scenario and might significantly affect the disease outcome. 
The prevention of STEVOR export on the iRBC surface may drastically affect 
the parasite survival probability in immune pressure conditions. As discussed 
in the previous section, the host immune system is in a constant process of 
developing antibodies against the surface exposed antigens on the infected 
RBC. STEVOR family on iRBC surface might act as another protective layer 
of antigenic variation which might confuse the immune system and reduce its 
efficiency and effectiveness to combat the disease. However, if the STEVOR 
does not get exported to surface and the particular PfEMP1 variant exposed in 
that life cycle remains exposed to immune system, the chances of host 
developing effective antibodies against the parasite exported antigen might 
improve. This, however, remains a topic for future investigations as the 
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Contribution of STEVOR alone in rosette binding strength: 
Average rosette binding force in 5A clone, F1 = 531.6pN; 
Average rosette binding force in A4(tr-I) clone, F2 = 425.7pN; 
Average rosette binding force in A4(tr-II) clone, F3 = 509.3pN; 
Therefore, average rosette binding force in STEVOR+strains       =  
                                                        
          
 
         
And, average binding force in A4 rosettes, FSTR = 91.8pN- 
Hence, the STEVOR generated rosette binding force =       -       = 
396.8pN 
 
